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ABSTRACT 
AN EXPLORATORY STUDY OF COPING, PSYCHOLOGICAL DISTRESS, 
SELF-ESTEEM AND PERCEIVED STRESS IN PATIENTS WITH CHRONIC 
BOWEL DISORDERS 
By 
GEORGINA CRA TCHLEY 
This study had 4 aims. The first aim was to explore the relationships between personal 
control and coping responses in patients with the chronic bowel disorders of irritable 
bowel syndrome (illS) and inflammatory bowel disease (ffiD). The second aim examined 
coping in ms and mo patients as a process, by focusing on a specific episode of their 
primary symptoms. The coping profiles of the ms and mo patients were compared to 
establish whether differences in coping between the 2 groups were present. The third aim 
examined differences between groups and tested for linear trends across ms, mo 
patients and Non-patient controls in relation to anxiety, depression and self-esteem. A 
supplementary aim was to evaluate whether anxiety in the 3 groups was considered to be 
clinically significant (i.e. feU above the threshold for "caseness"). The fourth aim tested 
differences between the 3 groups in perceived stress, as previous findings have been 
inconclusive. 
Fifteen ffiS patients and 15 ffiD patients who attended a Gastroenterology (G.I.) Clinic 
were interviewed and completed a battery of self-report measures. Fifteen Non-patient 
controls completed a battery of self-report measures. 
The data was analysed using Pearson's product moment correlation coefficients for aim 
I; profile analysis using MANOVA for aim 2, and one-way between subjects ANOVA's 
for aims 3 and 4. 
The research hypotheses were not met, as the results were not statistically significant. 
However, two post-hoc findings revealed that patients with bowel disorders used equal 
proportions of problem and emotion-focused coping and these types of coping were 
significantly positively correlated. The test of flatness within profile analysis was 
statistically significant which indicated that patients with bowel disorders do not use a 
"blanket" approach to coping with an episode of their primary symptoms. A percentage 
of people in each group met the criterion for "caseness" of clinically significant anxiety. 
The results were evaluated in relation to the research literature and directions for future 
research were outlined. 
It was suggested that there might be a subset of patients with bowel disorders who 
experience clinical anxiety and/or depression and screening in G.I. clinics was 
recommended. 
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CHAPTER 1: INTRODUCTION 
1.1 WHY THIS IS AN IMPORTANT AREA TO STUDY (Facts and Figures) 
Irritable Bowel Syndrome (ffiS) is a benign, chronic and common illness prevalent in 
approximately 20% of the Western population. ffiS has considerable cost (i.e. time, 
financial) implications reflected in utilization of health services and absenteeism from 
work. In the United States more than two million prescriptions per year are given out for 
people with ms (Sandler, 1990). This chronic illness is often associated with 
unnecessary and often harmful tests, procedures and surgery (Thompson, Dotevall, 
Drossman, Weaton & Kruis, 1989). For example, a study carried out in the U.S. by 
Whitehead, Cheskin, Heller, Robinson, CroweD, Benjarnin & Schuster, ( 1990) found that 
21% of their ffiS sample had undergone hysterectomies without benefit. The U.S. 
national average is 5.5%! People with ffiS who are referred to Gastroenterology Clinics 
account for over 500/o of the referrals. (K.umar & Clark, 1994; Francis & Whorwell, 
1997). ms has been ranked as the second most common cause of industrial absenteeism 
due to illness (Young, Alpers, Norland & Woodruff, 1976). 
In a prospective study of a community sample of 383 women, Whitehead, Crowel~ 
Robinson, Helier, & Schuster, (1992), found that psychological stress (as a consequence 
of stressful life events) was significantly related to the self-reported number of disability 
days and medical clinic visits for bowel symptoms. 
People with ffiS who seek treatment have higher levels of psychological distress 
compared to those who do not seek treatment (i.e. ms non-patients), (Lynn & 
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Friedman, 1995). illS patients are more anxious and depressed than control patients and 
tend to overuse medical services (Camilleri & Neri, 1989). 
The economic impact of this chronic illness is substantial. This warrants research 
endeavours to elicit more information about the impact of the illness on the patient. 
Although many studies have explored and identified the psychological distress associated 
with ms, there is limited research about how these patients cope with their illness and no 
research about how these patients cope with the primary symptoms of their illness. 
Studies addressing this neglected area begin to tackle the issues of reducing costs, 
benefiting not only the health care services but also the patients themselves. 
1.2 STRESS (how this relates to distress and coping) 
Waiter Cannon (1935) was among the first to use the term stress in a non-engineering 
context. He regarded stress as a disturbing force, which upsets the person's equilibrium 
or homeostasis. From this perspective, stress refers to those events or situations that 
challenge a person's psychological and/or physiological homeostasis. 
According to Lazarus (1966), for us to experience an event or situation as stressful we 
have to perceive or appraise it as such. Some appraisals can ameliorate the impact of a 
potentially stressful event. There are psychological mechanisms that may combat stress. 
Freud referred to these as defence mechanisms; today these are generally called coping 
strategies. 
For example, Pearlin and Schooler (1978) examined stress and coping in four role areas 
(i.e. marriage, parenting, household economics and occupation) in an adult community 
-10-
sample. They found a clear order in the efficacy of people's psychological resources in 
vitiating stress; freedom from negative attitudes towards self, the possession of a sense 
that one is in control of the forces impinging on one, and the presence of favourable 
attitudes towards one's self They also found that the greater the scope and variety of 
the individual's coping repertoire, the more protection coping affords. 
Glass and Singer (1972) provided evidence that the perception that one is in control of 
potentially stressful events reduces their impact. 
A widely used measure of perceived control in relation to personal health is the 
Multidimensional Health Locus of Control Scales (MHLC), (Wallston, Wallston, & 
DeVellis, 1978). Health locus of control refers to a person's beliefs regarding the source 
of control over his/her health. If the person believes that his/her own behaviour 
influences his/her health status, the person is said to possess an internal locus of control 
orientation with regard to his/her health. If, however, the person believes that his/her 
health is influenced by the actions of other people or is due to fate, luck or chance, the 
person is said to have an external health locus of control orientation. According to 
Wallston's (1984, 1992) modification of Rotter's (1954) social learning theory, a 
person's health locus of control orientation is one of several factors that determine which 
health-related behaviours a person will perform. The MHLC (Forms A & B) measure 
beliefs about peoples general health status. As it is possible that people with a given 
health condition may hold different locus of control beliefs about that condition than 
about their general health status Wallston, Stein & Smith, (1994) developed a 
disease-specific version of the MHLC (Form C), which can be adapted to any medical 
condition. 
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The studies by Pearlin & Schooler (1978) and Glass and Singer (1972), support Lazarus 
and Folkrnan's (1984) cognitive-phenomenological theory of stress which states that 
adaptation to a stressor is mediated by two factors; I) the personal appraisal of the 
stressor and of one's resources for dealing with it and 2) the thoughts and behaviours 
used to manage the demands of the stressors (i.e. coping responses). 
Appraisal is the cognitive process through which an event is evaluated with respect to 
what is at stake (primary appraisal) and what coping resources and options are available 
(secondary appraisal). Appraisals of stress are of three types: harm/loss (referring to 
damage that has already occurred); threat (referring to anticipated or future harm and 
challenge (in which the focus is placed positively on potential gain, growth or mastery 
rather than negatively on the possible risks). The degree to which a person experiences 
psychological stress (i.e. feels harmed, threatened or challenged) is determined by the 
relationship between the person and the environment in that specific encounter (Folkrnan 
and Lazarus, 1980). 
Lazarus ( 1993) states that, "An appraisal-centered approach to stress directs our 
attention not merely to environmental stressors but to how these stressors are construed 
by the person. I am confident that personal meanings are the most important aspects of 
psychological stress with which the person must cope, and they direct the choice of 
coping strategy". 
1.3 WHAT IS COPING? 
Lazarus and Folkrnan (1984) defined copmg as "the person's constantly changing 
cognitive and behavioural efforts to manage specific extemaVinternal demands that are 
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appraised as taxing or exceeding the person's resources". This definition emphasises the 
process, i.e. what people do when they are faced with psychological stress. Lazarus 
outlined two main types of coping responses (i.e. what people do), problem-focused (PF) 
and emotion-focused (EF). 
Problem-focused coping consists of efforts to change the actual circumstances of an 
adaptational encounter, e.g. by changing the environment or oneself This includes 
confrontive coping, self control, seeking social support, accepting responsibility and 
planful problem solving. Emotion-focused coping involves purely cognitive activities 
that do not directly alter the actual relationship with the environment but do alter how 
this relationship is cognized. This includes, distancing, escape-avoidance (e.g. wished 
the situation would go away or somehow be over with) and positive reappraisal. 
Changing the relational meaning of what is happening can be very powerful and widely 
employed for regulating stress and emotion. (Lazarus, 1992). 
1.4 COPING AND CHRONIC ILLNESS 
Folkman and Lazarus (1980) studied the appraisal and coping responses to stressful 
events experienced by a middle-aged community sample during one year. They found the 
context of the stressful situation (e.g. work related/health related) and the individual's 
appraisal of its amenability to personal control to be important predictors of modes of 
coping. 
Health-related stressors were associated with increased emotion-focused coping whereas 
work-related stressors were associated with higher levels of problem-focused coping. 
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This finding was consonant with situation-oriented studies of coping with physical illness 
and disabilities (e.g. Cohen & Lazarus, 1979; Lipowski, 1970 & Moos, 1977). 
In terms of appraisal, they found that situations in which something could be done and in 
which more information was needed generated higher levels of problem-focused coping 
than situations that had to be accepted. Situations that had to be accepted and in which 
the person had to hold back from acting, generated higher levels of emotion-focused 
coping than in those in which something constructive could be done. 
This finding supported Pearlin & Schooler's study (1978) which found that 
emotion-focused strategies were most effective in situations which were not amenable to 
individual control. More recently, Andrew Steptoe at the Conference of the European 
Health Psychology Society (1997), focused on the mounting evidence of the importance 
offeeling in control of stressors. 
Lazarus (1993) commented on the importance ofthe context in which illness occurs (i.e. 
at what stage, what threats are perceived etc.) in order to determine peoples' coping 
responses. "When studying how the patient copes with illness, it is necessary to specifY 
the particular threats of immediate concern to the patient and to treat them separately, 
rather than broadening the focus of attention to the overaU iUness". 
There are numerous studies of coping based on normal populations, but there are only a 
few studies of the coping strategies used by people with chronic illnesses. These can be 
broadly divided in to two categories, 1) studies which have examined the coping 
strategies of people with the same illness and 2) studies which have examined the coping 
strategies of people with a variety of chronic illnesses. 
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In the first category, Holm, Holroyd, Hursey & Penzien (1986), carried out a study 
comparing the coping strategies used by recurrent headache sufferers and headache-free 
controls. They found that recurrent headache sufferers used more emotion-focused 
strategies (avoidance and self-blame) and appraised ambiguous stressors as more 
negative and less controUable than the headache-free controls. Another study (Newman, 
Fitzpatrick, Lamb & Shipley, 1990) analysed 158 rheumatoid arthritis patients' responses 
to a measure of coping specifically designed for this population, using hierarchical cluster 
analysis. This produced a four group solution, i.e. four groups who coped using 
different strategies. A high proportion of R.A patients (n = 105) formed group 2 which 
did not show a distinctive coping strategy. These R.A patients tended to use a large 
range of coping strategies to a moderate extent. 
In the second category of studies, Bombardier, D'Amico & Jordan (1990), assessed the 
coping strategies used by 1 0 1 patients with a wide range of medical and psychiatric 
conditions which had been refractory to conventional medical or surgical treatment. The 
coping measure used was The Ways of Coping Checklist - Revised (WCCL-R) which 
asked patients to indicate which thoughts and behaviours they used to cope with their 
medical conditions. The WCCL-R has 5 subscales, problem-focused; seeks social 
support; wishful thinking; blames self and avoidance. Qualitatively the sample was 
characterised by relatively high utilisation of seeking social support (problem-focused 
coping strategy) and relatively little self-blame (emotion-focused coping strategy). When 
Bombardier et al, analysed the relative scores of coping (rather than the raw scores) to 
provide a means of comparing the proportion of coping effort attributable to each of the 
coping factors, they found that this heterogeneous sample used an equal amount of 
problem-focused (49%) and emotion-focused (51%) coping. 
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Bombardier et al's study did not support Folkman and Lazarus's (1980) finding that 
when faced with health-related stressors more emotion-focused strategies are used. The 
study is limited, because the findings can not be generalised to any single illness or 
condition. 
Another study which examined the coping strategies used by a sample of people with a 
variety of chronic illnesses was carried out by Felton, Revenson & Hinrichsen, (1984). 
However, they went one step further to make comparisons in terms of coping strategies 
between the different illness groups, to address whether people with chronic illnesses 
cope differently. The sample consisted of 170 adults with the chronic illnesses of 
hypertension, diabetes, cancer and rheumatoid arthritis. Most of the coping strategies 
were drawn from the Ways of Coping Scale. 
When the sample was taken as a whole, Felton et al found that people with chronic 
illnesses used a moderate amount of each coping strategy, with self blame being used the 
least often and threat minimization being used most often. In terms of the division of 
problem-focused and emotion-focused coping strategies, comparisons were not possible 
as unfortunately the measure used only had one problem-focused subscale and five 
emotion-focused subscales. 
When comparisons were made between different illness groups, they found that there 
were no significant differences in the types of coping between the groups; with the 
exception of people with rheumatoid arthritis, who used significantly more wish fulfilling 
fantasy. These results suggest that particular diseases are not exclusively linked with 
particular coping styles. However, differences among illnesses may have been partially 
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obscured by the use of the coping measure which asked about reactions to the iUness in 
general rather than to specific kinds of stress. 
The above studies are very difficult to compare, as comparison is fraught with 
methodological problems, such as the use of very different types of sample and a variety 
of coping measures. 
What the coping literature about chronic illnesses does tell us is that it is important to 
address perceptions of stress, appraisal and feelings of personal control when assessing 
peoples coping responses to chronic illness. It also highlights the importance of 
assessing a wide range of coping responses to identify if any specific strategies are used. 
Additionally, if a process-centered approach to coping is being examined, then there 
needs to be clarity/specificity about what aspect of the illness is being addressed. 
1.5 ms AND mD AS CHRONIC D..LNESSES 
Irritable Bowel Syndrome (IBS) is a gastrointestinal disorder characterised by the most 
common symptoms of abdominal pain or discomfort; abnormal bowel habits; abdominal 
distension; feelings of incomplete evacuation and mucus per rectum (Francis & 
Whorwell, 1997). 
ms is a recently recognised chronic illness prevalent in 15-200/o of the Western 
population. Recent reports suggest that this prevalence is similar in third world countries 
(e.g. Olubutide et al, 1995). People are usually given the diagnoses of ms in primary 
care settings, where the female to male ratio is 2.5: I and up to 50% of these people 
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attend Gastroenterology (G.I.) Clinics (Francis & Whorwell, 1997). ms is restricted to 
adults, it is uncommon in children and in people over the age of 60 years (Desai, 1982). 
Inflammatory Bowel Disease (JBD) is an umbrella term for Crohn's Disease (C.D.) and 
Ulcerative Colitis (U.C.) which are chronic gastrointestinal diseases. C.D. is 
characterised by the most common symptoms of diarrhoea, abdominal pain and weight 
loss and U.C. by the symptoms of diarrhoea with blood and mucus which is sometimes 
accompanied by lower abdominal pain or discomfort. (Kumar & Clark, 1994). 
ffiD has a worldwide distribution, but is more common in Western countries. ffiD can 
occur at any age but has a peak incidence between the ages of20-40 years old. C.D. is 
equally distributed between the sexes, but U.C. is more common in women than men. 
ms and mn are chronic illnesses which share primary symptoms of abdominal pain and 
abnormal bowel habits which occur episodically, vary in their severity and typically affect 
patients for years. (Schwarz, Blanchard, Berreman, Scharff, Taylor, Greene, Suls & 
Malamood, 1993). Both illnesses have unknown aetiology and are generally considered 
to be multifactorial in origin. Psychological factors are considered to have an important 
role in the exacerbation and perpetuation of both illnesses. 
1.6 PSYCHOLOGICAL MORBIDITY IN ms AND mD 
Living with a chronic illness is generally considered to be taxing and stressful. When 
people with ms have been directly asked about stress more than half of them have 
reported that stressful events exacerbate their symptoms (Ford, Miller, Eastwood & 
Eastwood, 1987). Clouse (1988) found that experimentally induced emotional stress 
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affects gastrointestinal motility. However, studies which have examined stressful life 
events or daily stress in ffiS sufferers have produced inconsistent results. For example, 
Suls, Wan, & Blanchard, (1994) did not find any consistent relationship between daily 
stressors and gastrointestinal (GI) symptoms in 44 patients with ffiS and Schwarz et al, 
( 1993) found no significant correlations between Life Events Scores and GI symptoms in 
109 ffiS patients. The latter study may have been limited because it measured life events 
per se as being indicative of stress rather than examining the perceived stress aroused by 
life events. A study by Arun, Kanwai, Vyas, & Sushil, (1993) found that ms patients 
perceived significantly more stressful life events compared to controls. A study by 
Whitehead et al, (1992) clarified that when perceived levels of stress were measured in 
relation to stressful life events then people with ms perceived significantly more of these 
when compared to controls. They also found that these levels of stress (in the ms 
group) were significantly correlated with the amount of subsequent bowel symptoms. 
However, the correlations were relatively low and indicated that approximately 11% of 
the variance in bowel symptom reports were attributable to life event stress. Whitehead 
et al (1992) examined several different approaches to the measurement of stress and 
bowel symptomatology and concluded that the correlation between stress and bowel 
symptoms was relatively low. 
In a review ofthe research examining the influence of distressing life events on ffiD, the 
results were inconsistent (Faller & Kraus, 1996). Schwarz et al, (1993) compared Life 
Events Scores between ffiS patients, mo patients and a control group and found no 
significant differences between the groups but an ordering of ffiS<ffiD<Controls. As 
mentioned above, this study provides limited information, as it did not examine the 
perceived amount of stress aroused by the life events. All of the studies examined the 
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effects of stress on iUness without accounting for the effects of coping responses which 
may have moderated these effects. 
Coping responses to perceived stress, such as living with the chronic illnesses of ms and 
mD are likely to affect symptomatology of the illness and any accompanying 
psychological distress. 
When examining the effects of perceived stress and coping in relation to chronic 
illnesses, it is important also to examine the amount of psychological distress, e.g. levels 
of anxiety and depression. Lazarus (1993) stated that, "the emotions are a much richer 
source of information about how people are faring in adaptational encounters, ... than the 
unidimensional concept of stress". 
As mentioned earlier, ms and mn are considered multifactorial in origin with 
psychological factors affecting how illness is experienced and acted on by patients. It is 
well documented in the literature that amongst the ms population, those who seek 
treatment are noticeably psychologically distressed, whereas the non-treatment seekers 
are not more psychologically distressed than the normal population. (Blanchard & 
Malamood, 1996; Drossman, McKee, Sandler, Mitchell, Cramer, Lowman & Burger, 
1988; Lynn & Friedman, 1995 & Whitehead, Bosmajian, Zonderman, Costa & Schuster, 
1988). 
Several studies have shown that ms patients score significantly higher on a variety of 
psychological measures compared to non-patient controls. For example, ms patients 
scored significantly higher than normals on the Beck Depression Inventory (BDI), and on 
both subscales of the State-Trait Anxiety Inventory (STAI). (Blanchard, Radnitz, Evans, 
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Schwarz, Neff & Gerardi, 1986 & Latimer, Sama, Campbell, Latimer, Waterfall & 
Daniel, 1981). The psychological profiles offfiS patients have been compared with other 
illnesses (e.g. Tension Headache, Migraine) and controls on 17 different psychological 
measures. On almost all of these it was found that the means were ordered ffiS>Tension 
Headache>Migraine>Normal Controls and the scores on the BDI were significantly 
higher for the ms group. (Blanchard et al, 1986). 
The research evidence for psychological distress in ffiD patients is mixed. A study by 
Gazzard, Price, Libby & Dawson, (1978) found a depression rate of 32-38% in 85 
outpatients with Crohn's Disease. When ffiD patients were assessed using the BDI, the 
mean score indicated that these patients were on the borderline for clinical depression. 
When the ffiD patients were separated into two groups, those with Crohn's Disease 
(C.D.) and those with Ulcerative Colitis (U.C.), it was found that the C.D. group had a 
mean score indicating mild depression and the U.C. group fell within the normal range 
(i.e. were not depressed). (K.inash., Fischer, Lukie & Carr, (1993a). These studies 
suggest that only some ffiD patients experience depression at a mild level. 
Tartar, Switala, Carra & Edwards, (1987) studied 53 ffiD patients (before and after 
disease onset) and compared them to normal controls. Tartar et al found that mD 
patients had increased prevalence of depression, anxiety and panic disorder in 
comparison to the controls at any time in their life. 
A study which helps to clarity the experience of depression and anxiety in ffiD patients 
was carried out by Porcelli, Leoci & Guerra (1996). They assessed anxiety and 
depression using the Hospital Anxiety and Depression Scale (HADS) in I 04 ffiD 
outpatients in conjunction with a measure of Disease Activity. Both the measures were 
used at baseline and at 6 months. The patients were grouped according to whether the 
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disease activity had remained unchanged, improved or worsened from baseline to follow 
up. Anxiety and depression were analysed separately using two-way repeated measures 
anova's, ie. both between groups and within group factors were examined as well as any 
interaction effects. Porcelli et al. found that for anxiety there were significant main 
effects of group, time and interaction. For depression there were significant main effects 
of time and interaction. These results showed that patients whose disease activity 
improved over time also had decreased levels of anxiety and depression over time. The 
patients whose disease activity had got worse over time showed the opposite effect in 
terms of anxiety and depression, (i.e. both anxiety and depression had increased over 
time). Porcelli et al. concluded that symptoms of psychological distress occur 
concurrently with the exacerbation of ffiD and recover with improvement in the clinical 
activity of the disease. 
There are four studies which have compared psychological distress between ms and 
mD patients and controls. These studies have produced inconsistent results in terms of 
finding significant differences between the two groups. The first study (Esler & 
Goulston, 1973) compared 2 ms groups (those with predominantly diarrhoea and those 
with predominantly pain) with an Ulcerative Colitis group and a Patient Control group. 
The 4 groups were compared on the Eysenck Personality Inventory (EPI) and the IPAT 
Anxiety Scale. They found that the ms group (with predominantly diarrhoea) were 
significantly more anxious and neurotic than the other 3 groups (i.e. ms with pain; U.C. 
and Patient Control). There were no other significant differences between the four 
groups. 
The second study (Fava & Pavan, 1976/77) compared ms patients with U.C. patients 
and an Appendicitis Control group. They found a 700/o prevalence of psychopathology 
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in the ms patients, which were predominantly depression and hysteria, in comparison to 
25% in U.C. patients and 15% in the appendicitis controls. 
The third study (Gomborone, Dewsnap, Libby & Farthing, 1995) compared three groups 
on the Beck Depression Inventory (BDI). They found that ms patients scored higher on 
the BDI compared to patients with an organic gastrointestinal disease and healthy 
controls. 
The fourth study (Schwarz et at, 1993) compared ffiS and ffiD patients and non-patient 
controls on a variety of psychological measures. These measures were as follows: BDI; 
State-Trait Anxiety Inventory; Rathus Assertiveness Scale (RAS); Psychosomatic 
Symptom Checklist (PSC); Social Readjustment Scale which yielded a single Life Events 
Score (LES) for the previous year and the MMPI. They found that with the exception of 
the RAS and MMPI scale 9., every psychological measure was ordered 
ffiS>ffiD>Controls. The ffiS and ffiD groups scored significantly higher than the 
controls on the BDI, the STAI and MMPI scales 0-3. However, the only significant 
difference which was found between the ffiS and ffiD patients was for anxiety. ffiS 
patients were significantly more anxious than ffiD patients. A finding that was supported 
by Walker, Roy-Byrne, Katon, L~ Amos, & frranek, (1990) where the SCL-90 was used 
to measure anxiety. 
Schwarz et al's study confirms the findings in the literature that ms patients' scores are 
higher than non-patient controls on psychological measures and that this holds true for 
ffiD patients. However, an interesting and important finding was that although the 
elevations in the scores were significant relative to controls, the scores did not reach 
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clinicaUy patbologicallevels. This may explain the variable results found in the studies 
on psychological distress in mo patients. 
All four studies suggest that ms patients are more psychologically distressed than mo 
patients. However, the only consistent finding of significant differences between these 
two groups was that ffiS patients are more anxious than ffiD patients. This is supported 
by a 5 year follow up study of ms patients where anxiety was considered important in 
the maintenance of the disease (Fowlie, Eastwood, & Ford, 1992). 
1.7 RATIONALE AND HYPOTHESES (1) 
The coping literature emphasises the importance of control in determining people's 
feelings of personal control when examining their coping responses, as control is an 
important predictor of the type of coping response used (i.e. problem-focused or 
emotion-focused). When people feel they have personal control over stressful situations, 
problem-focused coping predominates. When people perceive stressful situations as 
refractory to change, then emotion- focused coping predominates. 
It is therefore hypothesised that: 
la) There wiU be a positive correlation between internal health locus of control beliefs 
(IHLC) and the proportion of problem focused coping strategies across both patient 
groups. 
1 b) There will be a negative correlation between IHLC beliefs and the proportion of 
emotion focused coping strategies across both patient groups. 
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le) There will be a negative correlation between health locus of control beliefs due to 
chance (CHLC) and the proportion of problem focused coping strategies across both 
patient groups. 
1 d) There will be a positive correlation between CHLC beliefs and the proportion of 
emotion focused coping strategies across both patient groups. 
1.8 COPING AND ms AND ffiD 
There is very little research about the coping strategies of people with the chronic 
illnesses of illS and ffiD, a point that has been made by, Baer, Gagnon, Musgrove & 
Winston, (1982); Feife~ Strack & Nagy, (1987); Grace & Priest, (1982) & Meyer, 
Wolfish, Sachar, Greenstein, Hill & Janowitz, (1980). There is no study that has 
compared how these two patient groups cope with their illness. 
There are only two studies which have examined coping responses in ffiD patients. The 
first study (TumbuU & Vallis, 1995) used the Rosenbaum Self Control Schedule (SCS) 
which has been shown to predict coping and health care behaviours in a number of 
clinical samples. The SCS was used in conjunction with other measures assessing quality 
oflife in mo patients. Tumbull and Vallis found that coping was significantly negatively 
correlated with psychological distress (SCL-90R). When they split subjects into extreme 
groups on the coping scale, with 8 "good" capers and 8 "poor" capers they found that 
the "good" capers were significantly less distressed (SCL-90R) and less impaired {SIP 
Psychosocial Scale) than "poor" capers. Unfortunately, Tumbull and Vallis did not 
report the total mean score on the coping scale, nor how they discriminated between 
"good" and "poor" capers. The results are limited in providing information about how 
mo patients cope. 
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The second study (Kinash, Fischer, Lukie, & Carr, 1993b) involved assessing the coping 
behaviours of 150 ffiD patients (Crohn's Disease, N=88; Ulcerative Colitis, N=62) who 
had been diagnosed for at least one year. They used the Jalowiec Coping Scale (JCS) 
which consists of 40 coping behaviours, 15 problem-oriented and 25 affective-oriented. 
They found no significant differences between the coping patterns of the 2 mn groups. 
Both groups used significantly more problem-oriented coping strategies than 
affective-oriented strategies. 
There is only one study which has examined coping responses in illS patients. Lewis et 
al ( 1994) used the Ways of Coping Checklist retrospectively to assess coping strategies 
pre-to-post-illness in 47 ms patients. They found that ms patients used significantly 
more distancing, self controlling and seeking social support (post illness). These patients 
had expanded their coping repertoire to include more emotion-focused (33%) and 
problem- focused (67"/o) coping responses (post illness). 
These studies do not support the community sample ofFolkman & Lazarus, (1980) who, 
when faced with health-related stressors, tended to use more emotion-focused coping 
strategies. This may reflect a difference in coping between a normative sample and 
patient samples. 
A criticism of these studies is that they attempted to explain how people with illS and 
mD cope with their illness generally, using process-oriented coping measures. When 
coping is defined as a process rather than a trait concept it is important to examine the 
specific threats (or stressors) to the individuals concerned. A useful question to ask 
would be, "How do people with ms and mD cope with an episode of their primary 
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symptoms of abdominal pain and/or abnormal bowel movements". This is one of the 
aims of this study. 
1.9 RATIONALE AND HYPOTHESES (2) 
Taking in to account the differences found between these two chronic illnesses in terms 
of their psychological distress (as outlined in section 1.6), it is possible that they also 
differ in terms of the coping strategies they endorse when faced with an episode of 
abdominal pain and/or abnormal bowel movements. 
It is therefore hypothesised that: 
2) There will be a significant difference in the profile of coping strategies endorsed 
between IBS and IBD patient groups when coping with their most recent episode of 
abdominal pain and/or abnormal bowel movements. 
The research literature has shown that IBS patients' scores and IBD patients' scores are 
higher than non-patient controls on a variety of psychological measures. When IBS 
patients have been compared to IBD patients on measures of psychological distress (e.g. 
anxiety, depression, life events and MMPI) there has been a consistent ordering of 
IBS>IBD>Controls. One consistent significant difference that has been found between 
these two chronic illness groups is that IBS patients are significantly more anxious than 
IBD patients. A further finding was that elevations in anxiety scores did not reach 
clinically pathological levels for both IBS and IBD patients. 
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It is therefore hypothesised that: 
3) There will be significant differences in the anxiety scores between the 3 groups with 
the ordering ofmS>ffiD>Non-patient controls. 
4) The anxiety scores in each group (i.e. mo, ms and Non-patient controls) will not 
reach clinically significant levels. 
5) There wiU be a significant difference in the depression scores between the 3 groups 
with the ordering ofmS>ffiD>Non-patient controls. 
6) There will be a significant difference in the self esteem scores between the 3 groups 
with the ordering offfiS<ffiD<Non-patient controls. 
Perceived stress is another important variable to examine when studying peoples' coping 
responses to chronic illness. There is some evidence which indicates that ms patients 
perceive more stressful life events than controls. The results from research with mo 
patients are inconsistent. 
It is hypothesised that: 
7) There will be a significant difference in perceived stress scores between the ms, mo 
and non-patient control groups. 
1.10 SUMMARY 
This study has several aims. The first aim focuses on the issue of personal control in 
relation to coping responses, to establish whether the relationships found in previous 
studies can also be applied to people with the chronic illnesses ofms and mo. 
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The second aim is to examine coping in people with IBS and IBD as a process, by 
focusing on a specific episode of primary symptoms rather than focusing on the overall 
illness. Also, to assess a wide range of coping responses to identity if these two patient 
groups use any specific strategies and to compare their coping profiles to establish 
differences in coping. There are no studies that have compared how these two patient 
groups cope with the primary symptoms of their illness. 
The third aim focuses on psychological distress between patients with IBS, IBD and 
Non-patient controls in an attempt to replicate previous studies, especially Schwarz et 
al's (1993) findings that these groups are ordered IBS>IBD>Non-patient controls in 
terms of their anxiety and depression. Also to replicate the finding that anxiety does not 
reach clinically significant levels in these 3 groups and to establish whether a similar 
ordering is present in terms of self esteem, (i.e. IBS<IBD<Non-patient controls). 
The fourth and final aim focuses on perceived stress, as previous research has been 
inconclusive about the differences found in perceived stress between ms patients and 
Non-patient controls and IBD patients and Non-patient controls. There has been no 
study that has compared all 3 groups. 
Answers to the aims (as outlined above) have an important bearing on, 1) Clinical 
management/advice and 2) Future research examining the most effective coping 
strategies in dealing with these and possibly other chronic illnesses. 
-29-
CHAPTER 2: METHOD 
2.1 PARTICIPANTS 
There were 3 groups of participants. Group l = 15 patients with irritable bowel 
syndrome (ffiS); Group 2 = 15 patients with inflammatory bowel disease (ffiD) and 
Group 3 = 15 non-patient controls, (total n = 45). Groups l and 2 were diagnosed by a 
Consultant Gastroenterologist to ensure that they met the criteria for their diagnoses. 
(See Appendix 1). In order to obtain patient groups that were matched as closely as 
possible on their primary symptoms and age, the following exclusion criteria were 
applied: ms patients with mainly diarrhoea; ms patients with mainly constipation; under 
the age of 18 years old and over the age of 45 years old. Exclusion criteria for all 3 
groups were as follows: other major illness and reading difficulties in the English 
language. All 3 groups of participants were volunteers. There were 6 potential 
volunteers who were not included in the study; three of these decided they did not want 
to take part in the study; one was very difficult to contact and two were not eligible for 
the study as they met one or more of the exclusion criteria. 
2.1.1 Group I - ms patients 
This group consisted of 12 females and 3 males, whose ages ranged from 20 to 58 years 
(mean= 34.2, s.d. = 9.9). The group was predominantly Caucasian in origin (86%) and 
the mean Standard Occupational Classification (SOC) = 4. The mean duration of 
diagnosis was 1 year and 8 months with a mean duration of symptoms of 8 years and 6 
months. Three patients, (20%) were taking painkillers ; no patients were taking steroids 
and 8 patients (53%) were taking medication specifically prescribed for bowel disorders 
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at the time the study was conducted. Twelve patients (80%) had previously been treated 
with medication; none had previously had surgery and 1 patient (7%) had received both 
medication and surgery prior to taking part in the study. Ten out of the 15 ffiS patients 
(i.e. 67%) stated that living with their illness was stressful. 
2.1.2 Group 2 - mn patients 
This group consisted of 9 patients with Crohn's disease and 6 patients with Ulcerative 
Colitis. There were 12 females and 3 males, whose ages ranged from 19 years to 49 
years (mean= 34.8, standard deviation= 7.8). The group was lOO% Caucasian in origin 
and the mean SOC = 4. The mean duration of diagnosis was 3 years with a mean 
duration of symptoms of 7 years and 4 months. Two patients (13%) were taking 
painkillers ; 5 patients (33%) were taking steroids and 10 patients (67%) were taking 
medication specifically prescribed for bowel disorders at the time the study was 
conducted. Ten patients (67%) had previously been treated with medication; 2 patients 
(13%) had previously had surgery and 2 patients (13%) had received both medication 
and surgery prior to taking part in the study. Ten out of 14 ffiD patients (i.e. 71%) 
stated that living with their illness was stressful. One patient was unable to state whether 
this was the case or not. 
2.1.3 Group 3 =Non-patient controls 
This group consisted of 9 females and 6 males, whose ages ranged from 23 years to 56 
years (mean= 36.3, s.d. = 9.7). The group was 100% Caucasian in origin and the mean 
SOC = 4. This group did not have a bowel disorder, nor any other major health 
problem. 
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2.1.4 Demographic Group Comparisons 
There were significantly more females than males in the ms group, (Chi-square = 5.4, 
p<0.05) and in the ffiD group, (Chi-square = 5.4, p<0.05). There were no significant 
differences in gender in the Non-patient control group, (Chi-square = 0.6, p>0.05), but 
this group did consist of a female to male ratio of 3:2. There were no significant 
differences in age between the 3 groups, (one-way independent analysis ofvariance, F (2, 
42) = 0.494, p>0.05). There were also no significant differences in Standard 
Occupational Classification (SOC) between the 3 groups, (Kruskai-Wallis Test: 
Chi-square = 0.633, p>0.05). (For more detailed information about SOC, see Appendix 
2). Independent Samples T-Tests found no significant differences between the illS and 
ffiD groups in terms of the duration of their diagnosis, (t = -1.056, df = 28, p>0.05, 
two-tailed test) and the duration of their symptoms, (t = 0.41, df = 28, p>0.05, 
two-tailed test). 
2.2 SAMPLING 
The patient groups were purposeful samples, in the sense that those who were asked to 
volunteer met all the inclusion criteria (e.g. diagnostic criteria; between the ages of 18-45 
years old; no other major illness and being able to read the English language) and 
therefore formed homogeneous groups on this basis. Two patients in each group were 
over the age limit but included in the study due to the restraints of time. 
The non-patient control group was a convenience volunteer sample asked to participate 
on the basis that they matched the patient samples as closely as possible on age; that they 
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did not have a bowel disorder or any other major health problem and were able to read 
the English language. 
The size of the samples would determine the robustness of the findings. When 
examining the experimental effects of any study, two types of error can occur, called 
Type 1 (Alpha) and Type II (Beta) errors. A Type 1 error is the probability of falsely 
rejecting the null hypothesis, (i.e. saying there is an effect when this is not present). The 
level of Alpha (type I error) needs to be specified before research begins. The scientific 
community generally agrees that 0.05 is the minimum level of significance required. A 
Type II error is the probability of falsely accepting the null hypothesis, (i.e. saying there 
is not an effect when there is one present). Power is defined as the probability of 
correctly rejecting a false null hypothesis (i.e. 1-Beta). The Power of statistical tests to 
be able to detect real experimental effects in samples needs to be calculated before 
research is conducted, in order to estimate the sample sizes required to establish these 
effects. For example, if a sample size is too small then the results will not have sufficient 
power to ensure confidence in the results. 
2.2.1 Initial calculation of Power 
Before the study was conducted, a test of Power was calculated to determine the sample 
size for each group. As the majority of the group comparisons would involve the 
statistical analysis of variance (ANOVA), tables produced by Bratcher, Moran & Zimmer 
(1970) were used to estimate the sample size required to achieve a given power in the 
ANOVA 
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To establish the estimated sample size using these tables, values of C, Alpha, 1-Beta and 
p needed to be specified, where C = the ratio of differences between means to the square 
root of error variance (i.e. the effect size); Alpha = the level of significance; 1-Beta = the 
level of power and p =the number of treatment means being compared. 
Taking a small estimate of effect size, (i.e. C = 1.00) with a level of significance at 0.05 
(Alpha) and the level of power at 0.8 and p = 3 then the estimated sample size per group 
is 21. 
My initial aim was to obtain a sample size of 21 participants in each group which would 
meet the estimated sample size for a power of 0.8. (i.e. the study has an 80% chance of 
recording an accurate result or alternatively a 200/o chance of a Type II error). 
Due to limited time and the slow attrition of participants this was not met. The actual 
number of participants obtained in each group was 15. If the level of power is 
maintained at 0.8, then 15 participants in each group at the 0.05 level of significance has 
a consequence for C, i.e. effect size. The consequence is that C is increased to 1.25, 
which means that slightly larger differences between the groups will be detected. 
2.3 DESIGN 
As it is impossible to randomly allocate bowel disorders, this study was based on a 
quasi-experimental, independent groups design, and measures of associations between 
psychological processes and outcome measures. 
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2.4 SE'ITINGS 
Fifty percent of the patient groups (9 ffiD; 6 ffiS) were seen in a quiet room within an 
outpatient psychology department based in a general hospital. The remaining SO% of 
patients (5 ffiD; 10 ffiS), were seen within their own homes. 
The Non-patient control group participated in their own homes but did not have 
face-to-face contact with the researcher. 
2.5 MEASURES 
2.5.1 Measures used witb IBS and IBD patients (see Appendix 3) 
A Semi-Structured Interview designed to engage the participants and obtain factual 
information about themselves and their chronic illness. This includes discussion of a 
Symptom Checklist which the patients were given prior to the interview and brought 
with them, and priming the patients about their most recent episode of primary 
symptoms. 
A questionnaire battery consisting of 5 measures as follows: 
1. The COPE (Carver, C.S.; Scheier, M.F. & Weintraub, J.K, 1989), is a 
multidimensional coping inventory consisting of 60 self-report items which represent 1 5 
conceptually distinct scales of coping. These are as follows: 
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1. Active Coping: taking action, and exerting efforts, to remove or circumvent the 
stressor. 
2. Planning: thinking about how to confront the stressor, planning one's active coping 
efforts. 
3. Seeking Instrumental Social Support: seeking assistance, information, or advice 
about what to do. 
4. Seeking Emotional Social Support: getting sympathy or emotional support from 
someone. 
5. Suppression of Competing Activities: suppressing one's attention to other activities 
in which one might engage, in order to concentrate more completely on dealing with the 
stressor. 
6. Turning to Religion: increased engagement in religious activities. 
7. Positive Reinterpretation and Growtb: making the best of the situation by growing 
from it, or viewing it in a more favourable light. 
8. Restraint Coping: coping passively by holding back one's coping attempts until they 
can be of use. 
9. Acceptance: accepting the fact that the stressful event has occurred and is real. 
10. Focus on and Venting of Emotions: an increased awareness of one's emotional 
distress, and a concomitant tendency to discharge those feelings. 
11. Denial: an attempt to reject the reality of the stressful event. 
12. Mental Disengagement: psychological disengagement from the goal with which the 
stressor is interfering, through day-dreaming, sleep or self-distraction. 
13. Behavioural Disengagement: giving up, or withdrawing effort from, the attempt to 
attain the goal with which the stressor is interfering. 
14. Alcoboi/Drug Use: increased engagement in alcohol or drug use. 
IS. Humour: the use of humour directed at the situation. 
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The situational fonnat of the Cope was used which focuses on responses to a specific 
stressful situation, (i.e. the most recently experienced episode of abdominal pain and/or 
abnonnal bowel movements). Separate scores for each of the coping scales are 
computed by adding the scores of the four items that make up each scale. As the scores 
for each item range from, 1 = 'I did not do this at all' to 4 = 'I did this a lot', the scores 
for each coping scale range from 4 to 16. (i.e. the higher the score the more this type of 
coping was used). 
Carver et al. ( 1989) found that the COPE scales have high internal consistency 
(Cronbach's alpha > 0.6) with the exception of mental disengagement. Test-retest 
reliabilities ranged from 0.42 to 0.89 for the different scales (dispositional version). 
Construct validity was tested by correlating selected scales with measures of personality 
dimensions. Selected scales (i.e. I, 2 & 7) were found to correlate positively with 
measures of dispositional optimism and self-esteem, and negatively with trait anxiety. 
Selected scales (i.e. 11 & 13), displayed the opposite pattern of associations. 
2. A disease-specific version (i.e. MHLC Form C) of the Multidimensional Health 
Locus of Control Scale (MHLC). (Wallston, K; Stein, M.J. & Smith, C.A., 1994). This 
is an 18 item self-report measure of beliefs about control over illness. There are four 
subscales - internal, chance, external which includes doctors and other (powerful) 
people. There are 6 items for each of the internal and chance subscales and 3 items each 
for the two external subscales. The scores for each item range from 1 = 'Strongly 
Disagree' to 6 ='Strongly Agree'. Scores for each subscale range from 6 to 36 for the 
internal and chance subscales and 3 to 18 for the two external subscales. (i.e. the higher 
the score, the stronger the belief about control over illness). The subscales are 
orthogonal and therefore represent urn-dimensional factors. 
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The Mlll.C-Fonn C subscales have good internal consistency, alphas> or= 0.7 (range 
0.7-0.87). Test-retest reliability has shown stability coefficients ranging from 0.4 to 0.8 
for the subscales. To test the concurrent validity of Fonn C, Wallston et al. ( 1994) 
correlated it with Fonn B, and found that the subscales in Fonn C significantly correlated 
with their appropriate counterparts on Fonn B, (p<O.OOJ). 
3. Rosenberg's Self Esteem Scale 0965) is a 10 item Guttman scale designed to 
evaluate individuals' overall sense of being capable, worthwhile and competent. Five of 
the items are worded positively (1,2,4,6, & 7) and 5 negatively (3,5,8,9, & 10) in order 
to reduce response bias. The scores for each item range from, I ='Strongly Disagree' to 
4 = 'Strongly Agree'. The negatively worded items require reverse scoring. The total 
score ranges from 10 to 40, (i.e. the higher the score, the higher the self-esteem). 
4. The Hospital Anxiety and Depression Scale (HADS) designed by Zigmond & 
Snaith (1983) is a 14 item self-report measure of anxiety (7 items) and depression (7 
items) over a one week period. Each item is scored from 0 to 3. The total scores range 
from 0 to 21 for each subscale. (i.e. the higher the scores the greater the anxiety or 
depression). Scores from 8 to 10 on each subscale indicate possible clinical disorder and 
scores from 11 to 21 indicate probable clinical disorder. 
The HADS has good internal consistency, Cronbach's alpha= 0.93 for anxiety; 0.90 for 
depression, (Moorey, Greer, Watson, Gonnan, Rowden, Tunmore, Robertson & Bliss, 
1991 ). The concurrent validity was assessed by comparison with 5-point psychiatric 
rating scales of anxiety and depression for lOO medical out-patients. The HADS 
subscales significantly correlated with these ratings; r = 0.54 for anxiety and r = 0.79 for 
depression. (Zigmond & Snaith, 1983). Moorey et al. (1991) confirmed the construct 
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validity of the HADS as a measure of two factors, in a factor analysis of the responses of 
568 cancer patients. 
5. The Perceived Stress Scale (PSS-10) designed by Cohen et al (1983) is a 10 item 
self-report measure of the 'degree to which situations in one's life are appraised as 
stressful'. The ·1 0 items refer to subjective appraisals of events occurring within a 
one-month time frame. Items 1,2,3,6,9 & 10 are negatively worded and items 4,5,7 & 8 
are positively worded. The scores for each item range from 0 = 'Never' to 4 = 'Very 
Often'. The positively worded items require reverse scoring. The total score ranges 
from 0 to 40, (i.e. the higher the score the higher the perceived stress). 
The PSS-10 has good internal consistency, Cronbach's alpha was 0.84, 0.85 and 0.86 in 
three samples tested by Cohen et al. (1983) and 0.78 in a general population of 2,387 
people, (Cohen and Wtlliamson, 1988). Test-retest reliability should only be high over 
short time intervals, since perceived stress is affected by both daily hassles and the 
availability of coping resources. Over two days, test-retest reliability assessed in college 
students was 0.85, and over six weeks it was 0.55. Concurrent validity was tested in 
several studies of college students by correlating the PSS with measures of number of life 
events, ( r, ranging from 0.17 to 0.39) and impact oflife events, (r, ranging from 0.24 to 
0.49). (Cohen et al., 1983). The PSS-10 was validated using factor analysis which 
indicated two factors representing positively and negatively worded items, which 
explained 49% of the variance. (Cohen and Wiiliamson, 1988). 
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2.5.2 Measures used with Non-Patient Controls (see Appendix 4) 
Demographic information was obtained and a questionnaire battery consisting of 3 
measures as follows: 
1. Rosenberg's Self Esteem Scale (1965) : as detailed above. 
2. The Hospital Anxiety and Depression Scale (BADS) (Zigrnond & Snaith, 1983): as 
detailed above. 
3. Tbe Perceived Stress Scale (PSS-10) (Cohen et al, 1983): as detailed above. 
2.6 PROCEDURE 
Before this study was conducted it was approved by the Medical Research Ethics 
Committee, Southmead Health Services NHS Trust, Bristol on lOth June 1998. (See 
Appendix 5). 
2.6.1. Recruitment offfiS and mD patient groups 
Initially, all potential participants (i.e. those who met the inclusion criteria) were given an 
introductory leaflet by the Consultant when they attended appointments at the 
Gastroenterology Clinic. The introductory leaflet provided information about the study 
and the opportunity for patients to volunteer and consent to participation in the study. 
(See Appendix 6). In response to the low volunteer rate, (24% out of all potential 
participants approached) and the time limitation of the study, the consultant asked all 
potential participants to make a decision about volunteering at the time of their visit to 
the GI Clinic. (See Flowchart, pg. 42). 
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The volunteer participants' consent and personal details (i.e. name, address, telephone 
number and diagnosis) were posted to the researcher who contacted them by telephone 
to arrange an appointment. This was followed up with an appointment letter and the 
Symptom Checklist which participants were asked to complete prior to their 
appointment. (See Appendix 7). 
2.6.2. ms and mn patient groups participation 
The semi-structured interview was administered to each patient. The latter part of this 
interview asked the patient to describe the last time they had experienced an episode of 
primary symptoms. The purpose of this description was to prime the patient before 
responding to the first questionnaire in the battery to ensure that they were focusing on a 
specific episode of symptoms rather than responding generally to their illness. Each 
patient was given the questionnaire battery in the following order: the Cope; 
MHLC-Form C; Rosenberg's Self Perception; HADS and PSS-10. The instructions for 
each questionnaire were included in the battery. 
Each patient was given a brief synopsis about the aims of the study, (i.e. expanded on the 
information given in the leaflet) and were asked if they wanted to receive details about 
the outcome of the study. 
Each patient was reminded about the confidentiality and anonymity of participating in the 
study and were thanked for taking part. Questions which arose from patients were 
answered by the researcher and/or were advised to direct these towards the consultant. 
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FLOWCHART TO SHOW THE PROCESS OF RECRUITING VOLUNTEER 
PATIENT PARTICIPANTS 
July 1998 - 50 Introductory leaflets delivered to GI Clinic 
August'98 = 1 mn 
September'98 = no volunteers 
October'98 = no volunteers 
November'98 = 3 ffiD; 1 illS 
December'98 = 4 ffiD; 3 illS 
TOTAL= 12 volunteers (8 ffiD; 4 ffiS) 
12 out of 50 leaflets distributed= 24% volunteer rate 
All participated in hospital setting 
Consultant changed recruitment strategy 
Supplied more Introductory leaflets 
January'99 = 5 ffiD; 2 illS 
3 participated in hospital setting 
4 participated in their own homes 
No room availability in hospital setting as slow attrition rate led to running over 
time course of study, therefore bad to see remaining volunteers in their own homes 
February'99 = 2 ffiD; 5 illS 
March'99 = 4 illS 
TOTAL NUMBER OF VOLUNTEERS ELIGIBLE FOR STUDY = 
30 (15 IBD; 15 IBS) 
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2.6.3 Recruitment and participation of Non-patient control group 
Initially, potential control participants were recruited via the appointment letter to the 
patient, (i.e. volunteer patients were asked to bring a volunteer participant, e.g. fiiend or 
relative with them if possible). However, due to the fact that there was such a low 
response rate and that it was difficult to control for age using this strategy it was 
changed. Volunteer control participants who met the inclusion criteria formed this 
convenience sample, (i.e. were obtained by, "word of mouth"). 
The Non-patient control participants were sent the questionnaire battery with a covering 
letter which outlined the aims of the study; instructions for completing the battery; 
information about anonymity and thanks for their participation. (See Appendix 8). 
Before completing the battery they were asked to provide demographic information 
about themselves, (i.e. age, sex and occupation). The questionnaire battery was set out 
in the following order: Rosenberg's Self Perception; HADS and PSS-10. The 
instructions for completing each questionnaire were included in the battery. These were 
returned in the envelope provided to the researcher by hand or post. 
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CHAPTER3:RESULTS 
3.1 HYPOTHESES la-Id - PERSONAL CONTROL IN RELATION TO 
COPING RESPONSES 
Before these hypotheses could be tested. certain computations from the raw coping data 
needed to be carried out in order to find the proportions of problem-focused and 
emotion-focused coping. These were as follows: 
1. The 5 problem-focused copmg scales, (i.e. active coping, planning, seeking 
instrumental social support, suppression of competing activities and restraint coping) 
were summed, to establish the, "Total Amount of Problem-Focused Coping Score" for 
each patient. 
2. The 5 emotion-focused coping scales, (i.e. seeking emotional social support, religion, 
positive reinterpretation and growth, acceptance and denial) were summed, to establish 
the, "Total Amount of Emotion-Focused Coping Score" for each patient. 
3. The two totals were summed to obtain the, "Total Amount of Coping Score" for each 
patient. 
4. To obtain the PROPORTION of Problem-Focused Coping for each patient, the total 
problem-focused coping score was divided by the total amount of coping score. 
5. To obtain the PROPORTION of Emotion-Focused Coping for each patient, the total 
emotion-focused coping score was divided by the total amount of coping score. 
The means and standard deviations for each type of coping are displayed in Table I. 
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Total Amount Total Amount Total Amount Proportion of Proportion of 
of Problem- of Emotion- of Coping Problem- Emotion-
Focused Focused Focused Focused 
Coping Coping Coping Coping 
(min.=20, (min.=20, 
max.=80) max.=80) 
Mean 46.38 41.69 88.07 0.52 0.48 
Standard 13.03 8.77 19.64 0.05 0.05 Deviation 
N• 29 29 29 29 29 
• one patient was excluded from the computations due to missing data 
Table 1: Means and Standard Deviations for Problem and Emotion-Focused Coping for 
ms and mD Groups. 
To test Hypotheses la-Id, a statistical test of association was required. Before this was 
applied, consideration was given to the assumptions for the use of correlational data. 
These assumptions are as follows; that the sample must be representative; the variables 
being correlated must approximate a normal distribution; for every value of X, the 
distribution of Y scores must have approximately equal variability (this is called the 
assumption ofhomoscedasticity), and the relationship between X and Y should be linear. 
(Munro & Page, 1993). However, extreme outliers can severely affect the value of the 
correlation. 
These assumptions were taken in to account. Box-plots (see Appendix 9, Fig. 1.) 
revealed that there was one extreme outlier in the data. To avoid violating the 
assumption of normality this case was excluded from the analyses. The data met the 
requirements for a parametric test of association. Pearson's Product Moment 
Correlation Coefficients were performed on the data, using SPSS 7.5. 
Hypothesis 1 a: There will be a positive correlation between internal health locus of 
control beliefs (IHLC) and the proportion of problem-focused coping strateqies 
across both patient groups. 
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There was no significant correlation between Illl..C and the proportion of 
problem-focused coping strategies across patient groups, (r = -0.195, n = 28, p>0.05, 
one-tailed test). 
Hypothesis lb: There will be a negative correlation between HILC beliefs and the 
proportion of emotion-focused coping strategies across both patient groups. 
There was no significant correlation between Illl..C and the proportion of 
emotion-focused coping strategies across patient groups, (r = 0.195, n = 28, p>0.05, 
one-tailed test). 
Hypothesis le: There will be a negative correlation between health locus of control 
beliefs due to chance (CHLC) and the proportion of problem-focused coping 
strategies across both patient groups. 
There was no significant correlation between Clll.C and the proportion of 
problem-focused coping strategies across patient groups, (r = 0.237, n = 28, p>0.05, 
one-tailed test). 
Hypothesis ld: There will be a positive correlation between CHLC beliefs and the 
proportion of emotion -focused coping strategies across both patient groups. 
There was no significant correlation between Clll.C beliefs and the proportion of 
emotion-focused coping strategies across patient groups, (r = -0.237, n = 28, p>0.05, 
one-tailed test). 
Hypotheses 1a-1d were all rejected and the null hypotheses were accepted, i.e. that there 
were no associations between internal and chance health locus of control beliefs and type 
of coping strategies. Any associations were due to chance factors. 
Post-hoc results: There were two interesting post-hoc findings; 1) Visual inspection of 
the mean proportions of each type of coping strategies, indicated that the patients' used 
equal proportions of problem-focused and emotion-focused coping strategies (see Table 
1 above). This result was confirmed in a paired samples t-test, where the differences 
between the mean proportion of problem-focused coping and the mean proportion of 
emotion-focused coping was not significant, (t = -1.90, df = 28, p>O.OS, two-tailed test). 
2) There was a significant positive correlation between the total amount of 
problem-focused coping scores and the total amount of emotion-focused coping scores, 
(r = 0.608, n = 29, p<0.001, two-tailed test). (See Appendix 10, Fig. 2. for scatterplot). 
3.2 HYPOTHESIS 2: COPING PROFILES 
Profile analysis is a special application of multivariate analysis of variance (MANOV A) 
in which several dependent variables are measured and compared between two or more 
groups. (Stevens, 1986; Tabachnick & Fidell, 1996). Before applying profile analysis, 
certain assumptions about the data needed to be addressed. 
3.2.1 Assumptions of Data for Profile Analysis 
Multivariate normality: profile analysis is as robust to violation of normality as other 
forms of MANOV A. However, as the sample sizes were slightly unequal and the illS 
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sample had one less case than the number of dependent variables (i.e. 14 patients and 15 
D.V.'s) the distributions of the D.V.'s were examined for each group. Each patient 
group had 2 significant, positively skewed dependent variables, one of the D.V.'s was 
the same for each group. As only 3 out of the 15 D.V.'s across both groups were 
significantly skewed, normalising transformations were not performed on the data. 
Outliers: profile analysis is extremely sensitive to outliers. These were examined and 
several extreme outliers were found for 3 of the D.V.'s (i.e. AlcohoVDrug Use; 
Behavioural Disengagement & Religion). The outliers were retained in the analysis as 
they were considered to be clinically meaningful. 
Homogeneity of variance-covariance matrices: as the sample sizes were not highly 
divergent and there was no evidence of strong heterogeneity, this assumption was not 
violated. 
Linearity: of the relationships among D.V.'s is assumed for 2 of the tests within profile 
analysis (i.e. parallelism and flatness). This assumption was evaluated by examining 
scatterplots between all pairs of the D.V.'s and was not violated. 
Scaling: the measures used are assumed to have similar scaling or that they are 
commensurable. This is necessary as 2 of the tests in profile analysis use numbers which 
are the difference scores between the D. V.' s measured on adjacent occasions. The 
difference scores are called segments in the analysis. This assumption was not violated 
as the coping scales have the same range of possible scores, with the same value having 
the same meaning on all the measures (i.e. how much coping was endorsed). 
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3.2.2 Profile Analysis 
In profile analysis, 3 questions are tested on the data in the following order: 
I) 'Are the profiles parallel? If the answer to this were yes for two groups, it would 
imply that one group scored uniformly better than the other on all the variables'. 
2) 'If the profiles are parallel, then are they coincident? In other words, did the groups 
score the same on each variable?'. 
3) 'If the profiles are coincident, then are the profiles flat? In other words, are the 
means on all variables equal to the same constant'. 
(Stevens, 1986) 
Profile analysis was applied to the data (using SPSS 7.5), to answer the questions 
outlined above in order to test Hypothesis 2: There will be a significant difference in 
the profile of coping strategies endorsed between IBS and /BD patient groups when 
coping with their most recent episode of abdominal pain and/or abnormal bowel 
movements. 
The profiles of the illS and ffiD groups are shown in Fig. 3. 
The results are shown in Tables 2, 3 & 4. 
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Fig. 3: Profile Plots of the Mean Coping Responses for the 2 Patient Groups 
Value F Hypothesis Error df Significance 
df ofF 
lBS 
vs 0.54 1.18 14 14 0.383 
IDD 
Table 2: Profile Analysis: The test for Parallelism usmg a Multivariate test of 
significance- Pillai,s Trace. 
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Table 2 shows that there was no significant group by variable interaction for the IBS and 
ffiD groups, (Pillai's Trace Test, F (14, 14) = 1.18, p>O.OS). The exact probability of 
0.383 is greater than 0.05, therefore the profiles of the 2 groups did not deviate 
significantly from paraUelism, i.e. the results were consistent with the IBS and IBD 
groups having parallel coping profiles over all the coping strategies. It was therefore 
meaningful to proceed to test the second question in profile analysis, i.e. were the 2 
groups profiles coincident? 
Source of Sum of df Mean F Significance 
Variation Squares Square ofF 
Group (i.e. 54.98 1 54.98 1.17 0.28 ms&mo 
Within Cells 1,265.1 27 46.86 
Table 3: Profile Analysis: The test for Coincidence using a Repeated Measures 
Multivariate Test of Between-Subjects Effects. 
Table 3 shows that there was no significant difference between the IBS and ffiD groups 
profiles in terms of coincidence, (F (l, 27) = 1.17, p>O.OS). The exact probability of0.28 
is greater than 0.05, therefore the profiles of the 2 groups did not deviate 
significantly from coincidence, i.e. the results were consistent with the IBS and IBD 
groups scoring the same on each coping strategy. It was therefore meaningful to 
proceed to test the third and final question in profile analysis, i.e. were the 2 groups 
profiles flat? 
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Value F Hypothesis Error df Significance 
df ofF 
Coping 0.94 16.74 14 14 0.000 
Table 4: Profile Analysis: The test for Flatness using a Multivariate test of significance-
Pillai' s Trace. 
Table 4 shows that there was a significant difference between the coping variables within 
the IBS and IBD groups, (Pillai's Trace Test, F (14, 14) = 16.74, p<0.001). The exact 
probability of 0.000 is less than 0.001, therefore the profiles of the 2 groups were not 
Hat, i.e. the means of the coping strategies were significantly different. 
The results from the Profile Analysis found that the profiles of IBS and IBD patients 
were consistent with the absence of significant deviations from parallelism and 
coincidence. This means that the coping profiles of the coping strategies endorsed by the 
2 groups were not significantly different. Therefore, Hypothesis 2 was rejected and the 
null hypothesis was accepted. 
The test of flatness within Profile Analysis found a significant difference between the 
fifteen coping strategies endorsed within each patient group. 
It can be seen from Fig. 3., that the most frequently endorsed coping strategies in both 
patient groups were; Active Coping; Seeking Emotional Social Support and Acceptance. 
The least frequently endorsed coping strategies in both patient groups were; Turning to 
Religion; Denial; Behavioural Disengagement and Alcohol/Drug Use. 
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3.3 HYPOTHESES 3.4.5.6. & 7: ANXIETY. DEPRESSION. SELF-ESTEEM 
AND PERCEIVED STRESS IN ALL 3 GROUPS 
All these hypotheses, with the exception of hypothesis 4, required the statistical test of 
one-way independent analysis of variance (ANOV A). Before applying this test to the 
data, certain assumptions about the data needed to be considered. 
3.3.1 Assumptions of Data for One-Way Independent ANOV A 
The assumptions for ANOVA are as foUows: the dependent variable (D.V.) should be 
measured at the interval or ratio level; the groups should be mutually exclusive (i.e. 
independent of each other); the D.V. should be normally distributed and the groups 
should have equal variances, (i.e. the assumption of homogeneity of variance). 
ANOVA is considered to be fairly "robust" to departures from normality. To test the 
assumption of homogeneity of variance, Levene's homogeneity of variance test was 
applied to the data for each D. V. The results found no significant differences between 
the 3 groups for each D.V., (p>O.OS). Therefore the 3 groups had equal variances for 
each D. V. The data met the assumptions as outlined above. 
ANOVA tests the differences between the means of the groups. The means and standard 
deviations ofthe 3 groups on the D.V.'s are shown in Table 5. 
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Dependent IBS IBD CONTROL 
Variables Means & (S.D.) Means & (S.D.) Means & (S.D.) 
ANXIETY 7.87 (3.80) 8.13 (3.42) 6.60 (3.54) 
DEPRESSION 4.40 (3.58) 4.07 (3.71) 3.00 (2.10) 
SELF ESTEEM 33.87 (4.69) 32.67 (3.98) 31.33 (3.13) 
PERCEIVED 18.27 (6.47) 14.53 (6.32) 14.93 (4.18) 
STRESS 
Table 5: Means and Standard Deviations of the 3 Groups for Anxiety, Depression. 
Self-Esteem and Perceived Stress. 
ANOVA was performed on the data using SPSS 7.5, the results are shown in Tables 
6,7,8 & 9. 
Source of Variation Sum of df Mean F Significance 
Squares Square ofF 
BE1WEEN GROUPS 20.13 2 IO.o7 0.78 0.464 
Linear Term Contrast 12.03 1 12.03 0.93 0.339 
WITHIN GROUPS 541.07 42 12.88 
Table 6: One-Way Independent ANOVA for HADS- Anxiety. 
Hypothesis 3: There will be significant differences in the anxiety scores between the 
3 groups with the ordering of IBS>IBD>Non-patient controls. 
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There were no significant differences in anxiety between the 3 groups, (ANOV A, F (2. 
42) = 0. 78, p>O.OS). There was no significant linear trend in scores of the 3 groups, 
(Polynomial Linear Trend Test, F (1, 42) = 0.93, p>O.OS). 
Hypothesis 4: The anxiety scores in each group (ie. IBS, IBD and Non-patient 
controls) will not reach clinically significant levels. 
It can be seen from Table S, that on average the 3 groups fell below the cut-off, of 11, 
for probable clinical disorder on the HADS-Anxiety Scale. However, frequency data 
indicated that there were some people in each group that fell above the cut-off The 
percentage of people that met the criteria for probable clinical anxiety in each group 
were as follows: 27% of ms patients (n = 4); 20% of mD patients (n = 3) and 7% of 
Non-Patient Controls (n = 1). 
Source of Variation Sum of df Mean F Significance 
Squares Square ofF 
BETWEEN GROUPS 16.04 2 8.02 0.76 0.467 
Linear Term Contrast 14.70 I 14.70 1.42 0.240 
WITHIN GROUPS 434.53 42 10.35 
Table 7: One-Way Independent ANOVA for HADS- Depression. 
Hypothesis 5: There will be a significant difference in the depression scores between 
the 3 groups with the ordering of IBS>IBD>Non-patient controls. 
There were no significant differences in depression between the 3 groups, (ANOVA, F 
(2, 42) = 0.78, p>O.OS). There was no significant linear trend in scores of the 3 groups, 
(Polynomial Linear Trend Test, F (1, 42) = 1.42, p>O.OS). 
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Source of Variation Sum of df Mean F Significance 
Squares Square ofF 
BETWEEN GROUPS 48.18 2 24.09 1.52 0.231 
Linear Term Contrast 48.13 I 48.13 3.03 0.089 
WITHIN GROUPS 666.4 42 15.87 
Table 8: One-Way Independent ANOVA for Self-Esteem. 
Hypothesis 6: There will be a significant difference in the self esteem scores between 
the 3 groups with the ordering of IBS<IBD<Non-patient controls. 
There were no significant differences in self-esteem between the 3 groups, (ANOV A, F 
(2, 42) = 1.52, p>O.OS). There was no significant linear trend in scores of the 3 groups, 
(Polynomial Linear Trend Test, F (1, 42) = 3.03, p>O.OS). 
Source of Variation Sum of df Mean F Significance 
Squares Square ofF 
BETWEEN GROUPS 126.04 2 63.02 1.90 0.162 
Linear Term Contrast 83.33 I 83.33 2.52 0.120 
WITHIN GROUPS 1,391.6 42 33.13 
Table 9: One-Way Independent ANOV A for Perceived Stress. 
Hypothesis 7: There wiU be a significant difference in perceived stress scores 
between the IBS, TBD and non-patient control groups. 
There were no significant differences in perceived stress between the 3 groups, 
(ANOV A, F (2, 42) = 1.90, p>O.OS). A post-hoc contrast test showed that there was no 
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CHAPTER 4: DISCUSSION 
4.1 RESULTS IN RELATION TO AIMS AND HYPOTHESES 
The first aim of this study focused on the issue of personal control in relation to coping 
responses. Previous studies of normative samples established that control is an 
important predictor of the type of coping response endorsed in stressful situations. (e.g. 
Folkman & Lazarus, 1980; Pearlin & Schooler, 1978). These studies found that when 
people feel they have personal control over stressful situations, problem-focused coping 
predominates and when people perceive stressful situations as refractory to change, then 
emotion-focused coping predominates. 
Hypotheses la- Id tested whether these relationships could be found in people with the 
chronic illnesses of ms and mn. These patients were asked about their internal beliefs 
of control over their bowel disorders and beliefs about chance being in control over their 
bowel disorders. The relationships between these beliefs about control over their illness 
and the proportion of coping strategies (i.e. problem-focused and emotion-focused) 
endorsed were tested. The results found no associations between these variables; i.e. no 
significant relationships were found between internal and chance health locus of control 
beliefs about bowel disorders and type of coping strategies endorsed. These results 
suggest that the relationships between personal control and type of coping are not 
present in people with bowel disorders. Alternatively, these relationships may be present 
in people with bowel disorders but were not found in this study due to certain 
methodological and statistical limitations discussed in detail in the critique (Section 
4.2.1). 
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Two post-hoc results revealed interesting findings about coping in illS and ffiD patients. 
The first result found that when coping with a specific episode of their primary 
symptoms, ms and mo patients used equal proportions of problem-focused and 
emotion-focused coping. This finding does not tend to support the work of Folkman & 
Lazarus (1980) who found that when faced with health-related stressors people use more 
emotion-focused coping, nor does it support situation-oriented studies of coping with 
physical illness and disabilities whose findings were consonant with Folkman & Lazarus 
(1980), e.g. Cohen & Lazarus, (1979); Lipowski, (1970) & Moos, (1977). However, 
this finding does support Bombardier et al' s ( 1990) results of a heterogeneous sample of 
patients with a wide range of medical and psychiatric conditions that also used equal 
proportions of problem and emotion-focused coping. 
The findings (outlined above) suggest that patient samples vary from normative ones in 
their utilisation of coping and, that different illnesses may lead to different types of 
coping strategy utilisation. However, the discrepancy in findings between certain types 
of coping strategy utilisation may reflect differences between the coping measures used 
and the interpretation of those measures. This is a common difficulty when making 
comparisons between studies and means that general conclusions need to be made with 
caution. 
The second result found that, when ms and mo patients coped with a specific episode 
of their primary symptoms, there was a significant positive correlation between the total 
amount of problem-focused coping and the total amount of emotion-focused coping. 
Therefore the more these patients endorsed problem-focused coping; the more they 
endorsed emotion-focused coping and vice versa. This finding suggests that the 2 types 
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of coping are not independent and therefore both types contribute to the management of 
dealing with a stressful episode of abdominal symptoms. 
The second aim of this study was to examine coping in people with ms and mo as a 
process, to explore whether these patients differed in terms of their coping profiles when 
coping with their most recent episode of primary symptoms. There are no previous 
studies comparing these two patient groups in relation to coping. On the basis of prior 
research, which found differences between these 2 groups in terms of their psychological 
distress, it was hypothesised that there would be differences between these 2 groups in 
terms of their coping strategies, (i.e. Hypothesis 2). 
The results from the Profile Analysis found no significant differences between the 2 
groups on tests of parallelism and coincidence. This result suggests that ms and ffiD 
patients have similar coping profiles when coping with their most recent episode of 
primary symptoms. However, significant differences between the 2 groups may exist but 
were not found in this study due to the relatively small sample sizes in relation to the 
number of different coping strategies which were analysed. 
The test of flatness within Profile Analysis found a significant difference between the 1 S 
coping strategies endorsed by the ms and ffiD patients combined. This result indicates 
that ms and mo patients do not use a "blanket" approach to coping with an episode of 
their primary symptoms, but utilise particular coping strategies more than others. The 
most frequently endorsed strategies were, Active Coping, Seeking Emotional Social 
Support and Acceptance. The least frequently endorsed strategies were, Turning to 
Religion, Denial, Behavioural Disengagement and AlcohoVDrug Use. With the 
exception of Denial these latter strategies were the ones which produced extreme outliers 
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in the data. The outliers represented people who overall used these strategies a 
moderate amount in comparison to the remainder of the sample who on average did not 
use these strategies at all. Implications about the frequencies of particular coping 
strategies will be discussed in the critique, (Section 4.2.2). 
The tbird aim of this study focused on differences in psychological distress between 
patients with IBS, IBD and Non-patient controls to replicate previous findings (e.g. 
Schwarz et al, 1993) about, a) significant differences between these 3 groups and b) 
significant trend toward ordering of IBS>IBD>Non-patient controls in terms of their 
anxiety and depression. Also to explore whether these findings are similar with regard to 
self-esteem between the 3 groups. Finally, to replicate the finding in Schwarz et al's 
study that anxiety does not reach clinically significant levels in these 3 groups. 
Hypotheses 3,5 & 6 tested the differences and the ordering between the 3 groups in 
terms of their anxiety, depression and self-esteem. The results found no significant 
difference in these variables between the 3 groups, nor any significant trend across the 3 
groups. The findings for anxiety and depression are surprising, given that they do not 
support a substantial number of previous studies which have found that IBS patients 
scores are higher than Non-patient controls and, when all 3 groups have been compared, 
both IBS and IBD patients' scores are higher than Non-patient controls. The results did 
not replicate the findings of Schwarz et al ( 1993) that these groups were ordered 
IBS>IBD>Non-patient controls. In light of the findings for anxiety and depression, it 
does not seem surprising that no significant results were found for self-esteem between 
the groups, nor was there an ordering of IBS<IBD<Non-patient controls. An interesting 
observation is that the self-esteem scores in all the groups were reasonably high, i.e. the 
means were all over 30, (maximum score= 40). 
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Hypothesis 4 aimed to replicate the findings of Schwarz et al ( 1993) that the anxiety 
scores in each group would not reach clinically significant levels, i.e. the scores would 
fall below the threshold for "caseness". Initially the mean values indicated that this held 
true for the 3 groups as the means fell below the cut-off for probable clinical anxiety 
disorder (i.e. "caseness"). However, frequency data indicated that there was a 
percentage of people who did fall above the cut-off for probable clinical anxiety in all 3 
groups, (i.e. 27% illS, 20% ffiD and 7% Non-patient controls). Therefore, this finding 
did not support Schwarz et al's (1993) study in relation to "caseness". The implications 
of these findings will be discussed in more detail in the critique, (Section 4.2.2). 
The fourth and final aim of this study focused on perceived stress, as previous studies 
have been inconclusive about the differences found in perceived stress between ms 
patients and Non-patient controls, and ffiD patients and Non-patient controls, and no 
previous studies have compared all 3 groups. 
Hypothesis 7 tested the differences between the 3 groups in terms of their perceived 
stress and found that there were no significant differences between the groups. A 
post-hoc linear contrast test also found no significant ordering effect over the 3 groups. 
This finding suggests that when people are asked about their perceptions of stress rather 
than the number of stressful life events they have experienced per se, people with the 
chronic illnesses of illS and ffiD do not differ from Non-patient controls. However, 
differences between the groups may exist in terms of perceived stress but were not found 
in this study due to methodological and statistical limitations (discussed below). The 
research evidence to date remains inconclusive about any differences that may exist 
between groups in terms of perceived stress. 
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4.2 CRITIQUE 
4.2.1 Metbodological & Statistical Implications 
The null hypotheses were accepted and the research hypotheses were rejected in this 
study, as all the results were greater than an alpha of0.05. Although the most obvious 
conclusion is that the expected differences between groups and associations between 
variables, do not exist in ffiS, ffiD and Non-patient populations, it is possible that they 
went undetected in this sample for several reasons. 
Firstly, the samples for each group consisted of volunteers. The characteristics of people 
who volunteer their participation in studies can differ from the rest of the sample they 
represent (Silverman, 1985). This means that interpretations of the findings need to be 
evaluated with caution, in terms of the ability to generalise to the rest of the population 
they represent, (i.e. in this study the ffiS, ffiD and Non-patient control populations). 
Secondly, due to the actual sample size obtained, the power of the statistical tests could 
only detect relatively large differences between groups (i.e. C = 1.25) in terms of effect 
size. Therefore it is possible that a larger sample may have produced significant results. 
However, C = 1.25 represents a reasonable estimate of an effect size corresponding to a 
difference in therapeutic or clinical effectiveness, and it is questionable whether the 
statistically significant (but therapeutically small) differences detectable in a large sample 
would have practical implications for treatment. 
Thirdly, a confounding variable may have been present in the mn group. As ms is so 
common it can coexist with other disorders, such as mn. For example, a study by lsgar, 
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Hannen, Kaye & Whorwell (1983), found a high prevalence offfiS symptoms in a group 
of patients with Ulcerative Colitis in remission. As patients with Ulcerative Colitis were 
included in the mo category in this study, it is possible that some of the mo patients 
also have ms. This would have introduced a confounding variable in the study, which 
may account for the lack of significant differences between the ms and mo groups. 
Due to time constraints a single measurement of coping with a specific episode of 
primary symptoms was obtained in the ffiS and mo groups. Repeated measurements of 
specific episodes which were then aggregated for each person would have provided a 
more reliable (i.e. stable) measure of how people with ms and ffiD cope with a specific 
episode of their primary symptoms. 
The validity of the coping strategies endorsed by ms and mo patients may have been 
inaccurate, as they responded retrospectively about their last episode of primary 
symptoms. Although the most common episode was within a week, the range of 
episodes varied from a few days ago to 2 years and 2 months ago. Therefore, some of 
the patients' memories of what they actually did may have been inaccurate, despite the 
priming technique in the interview, which attempted to overcome this problem. 
Taking the above comments into account, the findings from this study cannot be 
generalised to the general ms and mo populations that attend G.I. Clinics. 
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4.2.2 Clinical Issues 
Two issues emerged from the findings that are interesting from a clinical viewpoint. One 
of these relates to anxiety and the other relates to the coping strategies endorsed by IBS 
and ffiD patients. 
The research literature about psychological distress in ms patients who seek treatment 
has found that these patients have higher levels of psychological distress than 
non-treatment seekers and non-patient controls. This has been shown on a multitude of 
variables including anxiety and has led to the claim that treatment seekers are vulnerable 
to and have a higher prevalence of psychiatric disorders. Over the last I 0 years, several 
authors have attempted to counteract this claim, arguing that psychiatric disorders in this 
population are not as high as previous studies have claimed (e.g. Thomton, Mclntyre, 
Murray-Lyon & Gruzelier, 1990), and taking this one step further, that elevations in 
psychological measures of distress in this population do not reach clinically significant 
levels, (e.g. Schwarz et al, 1993). 
ln Thomton et al's ( 1990) study of 25 patients with ms, only 4 met the criteria for 
psychiatric disorder. What is of greater interest in relation to the present study are the 
findings for the remaining 21 non-psychiatric cases of ffiS. Scores on the STAJ were 
below average for general medical and surgical patients (this measure was the same one 
used by Schwarz et al, 1993) and this supports their argument that elevations did not 
reach clinically significant levels. However, scores on the HADS revealed that 4 of the 
ms patients had clinically significant levels of anxiety and none of the ms patients had 
clinically significant levels of depression. 
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This latter finding is similar to the present study where 4 out of the 15 ms patients met 
the criterion for clinically significant anxiety, and 1 ms patient met the criterion for 
clinically significant depression on the HADS. In the ffiD group, 3 out of the 15 patients 
met the criterion for clinically significant anxiety, and 2 mn patients met the criterion for 
clinically significant depression on the HADS. An interesting anecdotal finding was that 
33.3% of patients with bowel disorders had felt anxious/concerned about the possibility 
of having bowel cancer. When these patients had been reassured that this was not the 
case (usually by having a colonoscopy), they reported that their anxiety had dissipated. 
These findings suggest that anxiety may be elevated at certain points in time, depending 
on the duration of the illness and bowel symptom activity. These may account for the 
varying results in previous studies. It also suggests that there may be a subset of patients 
with bowel disorders that experience clinically significant levels of anxiety and depression 
throughout their illness experience. 
Several issues are raised in relation to the findings about the coping strategies the ms 
and ffiD patients endorsed. The study by Bombardier et al. (1990) found equal 
proportions of problem and emotion-focused coping in a heterogeneous sample. These 
findings were limited, as they could not be generalised to any single illness or condition. 
The findings in the present study add support to the equal proportions claim and when 
analysed separately (as well as together) suggest that ms and mn patients' use equal 
proportions of both types of coping strategies. 
The coping strategies endorsed by patients with bowel disorders when coping specifically 
with an episode of primary symptoms are worth attending to, despite the methodological 
limitations. The frequency of particular coping strategies indicates that this sample of 
patients were using potentially adaptive coping strategies to manage their episode of 
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primary symptoms. This observation is based on results from Carver et al' s ( 1989) 
paper, where they found significant correlations between some of the scales on the 
COPE and certain personality dimensions. The personality dimensions of interest to the 
present study are self-esteem and anxiety. The most frequently used coping strategy in 
the present study was Active Coping. Carver et al., (1989) found that Active Coping 
was correlated positively with self-esteem and negatively with anxiety. Two of the least 
frequently used coping strategies in the present study were Denial and Behavioural 
Disengagement. Carver et al., (1989) found that both these strategies were negatively 
correlated with self-esteem and positively correlated with anxiety. These correlations 
suggest that Active Coping is adaptive and Denial and Behavioural Disengagement are 
maladaptive. The patients in this study, on average had high levels of self-esteem and 
low levels of anxiety. These findings indicate the possibility that this sample used 
adaptive coping strategies, but is not in any way conclusive, due to methodological 
limitations, (e.g. the time between last episode of primary symptoms varying; intervening 
variables between last episode and measurement of anxiety and self-esteem were not 
assessed; only one measurement of coping with a specific episode was taken; duration of 
illness since diagnosis varied, etc.). Therefore, it can only be tentatively implied that this 
sample of patients, who had been diagnosed on average over 1.5 years ago, coped 
positively with a specific episode of their primary symptoms. 
4.3 DIRECTIONS FOR FUTURE RESEARCH 
This study was explorative in nature, as it was the first attempt to assess the coping 
process in patients with ffiS and ffiD. A strength of this study was that it assessed a 
wide range of coping strategies. The conclusions that can be drawn from this study were 
limited, primarily due to constraints of time, which led to a relatively small sample size, 
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single measurements and design limitations. Future research needs to direct attention to 
the following: 
Coping with chronic illnesses often changes over time (Lazarus, 1992; 1993; Weinman, 
1987). A cross-sectional design targeted at varying durations of the chronic illnesses of 
ms and ffiD would address this issue. Ideally this cross-section of patients would then 
be assessed longitudinally, to allow for repeated measurements of psychological distress, 
self-esteem and coping with specific episodes of their primary symptoms. Preferably, 
there would also be a measure to indicate how the episode was construed and appraised, 
(as it was interesting to note that not all the patients in the present studied viewed their 
illness as stressful). To reduce inaccuracies in memory, patients would be asked to 
complete the coping measure at the time the episode was experienced. 
A cross-sectional, longitudinal design as outlined above would lead to a better 
understanding of the coping process in patients with ms and mn and identify both 
consistencies and inconsistencies in the coping profiles they endorse. It would also aid 
our understanding about how the coping process relates to psychological distress and 
self-esteem. This may lead on to further research, which could address the relationships 
between coping and adaptational outcomes and identify the efficacy of particular coping 
strategies for positive psychological health. It is worth noting that adaptational outcome 
requires a measure of health status. For these patients it would be meaningful to assess 
their quality of social functioning, as anecdotal data indicated that this was an area that 
could be greatly affected by an episode of primary symptoms. 
-68-
4.4 IMPLICATIONS FOR PRACTICE 
The research about coping in IBS and IBD patients is just beginning and it would be 
premature to draw any conclusions about the implications for clinica.Umedical practice. 
An issue which at present does have implications for clinica.Umedical practice, is the 
psychological distress experienced by patients with IBS and IBD that was discussed in 
Section 4.2.2. The conclusions that were drawn from the findings suggested that there 
might be a subset of patients with bowel disorders who experience clinically significant 
levels of anxiety and depression throughout their iiiness experience. The implications of 
this finding advocate for the use of a measure of anxiety and depression to be 
implemented in all Gastroenterology Clinics to screen for this subset of patients. Once 
identified, these patients should be offered a psychological referral for assessment and 
intervention. The intervention offered would be dependent on the resources and 
protocols established and available in each locality. For example, this could vary from 
patients being referred on to mainstream psychology services or health psychologists 
available within the hospital setting. The intervention may be individual or group based 
depending on the current practices of the providers for mental health support services. 
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54 Wades Road 
Filton 
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Diagnosis of Irritable bowel Syndrome 
l A positive diagnosis should be made from symptoms rather than 
by exclusion. 
2 Symptoms vary between patients and not all patients have all 
recognized symptoms. 
3 The main symptoms identified are recognized in the manning 
criteria. Many of them are minor features, however, are 
recognised by gastroenterologists. 
4 Symptoms include abdominal' pain relieved by defaecation, the 
passage of mucus in the stool, disordered bowel habit, 
including constipation and diarrhoea, an association between 
the abdominal pain and the bowel disturbar1ce, a sensation of 
incomplete evacuation and bloating. 
5 Less frequently identified symptoms are psuedo constipation, 
pseudo diarrhoea, an exaggerated gastro colic reflex and ever1 
frequency of micturition. 
6 Patients over the age of 45 are not diagnosed with irritable 
bowel syndrome without a barium enema to exclude colon cancer 
and inflammatory bowel disease. 
7 A diagnosis of irritable bowel syndrome is not accepted if the 
patient has any alarm symptoms such as rectal bleeding, weight 
loss or extra intestinal manifestatior1s suggesting inflammatory 
bowel disease. 
B Using the above criteria it is rare to rniss diagnose colon cancer, 
but occasional cases of inflammatory bowel disease, especially 
Crohn's disease are missed. 
9 The diagnosis is made in my patients by clinical history, 
examination and rigid sigmoidoscopy witl1 supplementary tests 
as necessary. 
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Diagnosis of Inflammatory bowel disease 
1 The diagnosis is based on appropriate symptoms, physical signs and 
investigation results. 
2 The symptoms suffered by patients with inflammatory bowel disease vary 
on the type of inflammatory bowel disease and the site of the problem. 
3 Patients with Crohn's disease present with diarrhoea, abdominal pain 
and sometimes rectal bleeding. 
4 Patients with ulcerative colitis present with diarrhoea and rectal 
bleeding, but rarely have significant pain. ~eight loss may be a 
feature of both Crohn's disease and ulcerative colitis. Blood tests 
may show signs of inflammation and sigmoidoscopy will show 
inflammation if the rectum is involved. If disease is confirmed to 
the small bowel it may show on contrast studies. 
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APPENDIX2 
General Nature of Qualifications. Training and Experience for Occupations in 
SOCM. G aJOr rouos 
No. Major Group General Nature of Qualifications, Training & 
Experience for Occupations in the Major Group 
l Managers& A significant amount of knowledge and experience of the 
Administrators production processes, administrative procedures or service 
requirements associated with the efficient functioning of 
organisations and businesses. 
2 Professional A degree or equivalent qualification, with some occupations 
Occupations requiring post graduate qualifications and/or a formal period of 
experience-related training. 
3 Associate Professional An associated higb-level vocational qualification. often involving a 
& Technical substantial period of full-time training or further study. Some 
Occupations additional task-related training is usually provided througb a 
formal period of induction. 
4 Clerical & Secretarial A good standard of general education. Certain occupations will 
Occupations require further additional vocational trnining to a well defined 
standard (e.g. typing or shorthand). 
5 Craft & Related A substantial period of training, often provided by means of a 
Occupations work-based training programme. 
6 Personal & Protective A good standard of general education. Certain occupations will 
Service Occupations require further additional vocational training, often provided by 
means of a work-based training programme. 
7 Sales Occupations A general education and a programme oh•ork-based training 
related to sales procedures. Some occupations require additional 
specific technical knowledge but are included in this major group 
because the primary task involves selling. 
8 Plant & Machine The knowledge and experience necessary to operate vehicles and 
Operatives other mobile and stationary machinery, to operate and monitor 
industrial plant and equipment, to assemble products from 
component parts according to strict rules and procedures and 
subject assembled parts to routine tests. Most occupations in this 
major group will specify a minimum standard of competence that 
must be attained for satisfactory performance of the associated 
tasks and will have an associated period of formal 
experience-related training. 
9 Other Occupations The knowledge and experience necessary to perform mostly simple 
and routine tasks involving the use of hand-held tools and in some 
cases, requiring a degree of physical effort. Most occupations in 
the major group require no formal educational qualifications but 
will usually have an associated short period of formal 
experience-related training. All non-managerial agricultural 
occupations are also included in this major group, primarily 
because of the difficulty of distinguishing between those 
occupations which require only a limited knowledge of agricultural 
techniques, animal husbandry, etc. from those which require 
specific trnining and experience in these areas. These occupations 
are defined in a separate minor group, 
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A•PPENDIX3 
-I .• - --· . - . . .. . . 
SEMI-STRUCTURED' INTERVIEW. 
PAR:riCWANTNO: 
AGE:: 
~sEX:; 
OCGUPA:ifiON: 
ETHNIC ORIGIN: 
. . ' 
.MEDICA:rloN: 
PREWe.usntREATMENTS: 
GROUP: IBSIIBI) 
Clieck Ct,J"'ffleied'tlte Symptom' CheckliSt, then :ask: ihe questionS, beltJui': 
WhM d() you find! helps make thesnymptoms ibetter.?' 
Whatido you find makes, these: symptoms worse? 
Do you find living with(your illness. stressful? :Y,ES/N(). 
What concerns you the most about yollr illness? 
I 
' ; 
.. 
i..- } 
H 
I'..:~ 
' < 
,,- ·" 
·' '\ 
When•did you last:experience!an• episode· ofabdomililil painlaiid/or abnormal I 
'bo~el ·movements? (tiSk,persontto describe ihis:e'xperlence). 
Giviilj}aiieirt descijptor:c(Ud: · 
ANSWER: ti Z' 3 4 1(c;ircle the ·answer the.paiient give5) 
-7.6-" 
RESEARCH QUESTIONNAIRE BATTERY 
NAME: ............................................................................................................ . 
DATE: ...................................... . 
COPE 
GROUP: ffiS/IBD 
PARTICIPANT NO: 
Please think about the last time you experienced an episode of abdominal pain and/or abnormal bowel movements 
and how you reacted to this. Then indicate the extent to which you did whatever each of the following statements 
says by circling one number for each, using the rating scale shown in the box. 
Please try to respond to each statement separately in your mind. 
Choose your answers thoughtfully, and make your answers as true 
FOR YOU as you can. Please answer every statement. There are no 
'right' or 'wrong' answers, so choose the most accurate answer for 
YOU. 
1. I tried to grow as a person as a result of the experience. 
RATING SCALE 
1 = I did not do this at all 
2= I did this a little bit 
3= I did tbis a medium amount 
4= I did tbis a lot 
2 3 4 
2. I turned to work or other substitute activities to take my mind off things. 2 3 4 
3. I got upset and let my emotions out. 2 3 4 
4. I tried to get advice from someone about what to do. 2 3 4 
5. I concentrated my efforts on doing something about it. 2 3 4 
6. I said to myself"this isn't real". 2 3 4 
7. I put my trust in God. 2 3 4 
8. I laughed about the situation. 2 3 4 
9. I admitted to myself that I couldn't deal with it, and gave up trying. 2 3 4 
10. I restrained myself from doing anything too quickl}'. 2 3 4 
11. I discussed my feelings with someone. 2 3 4 
12. I used alcohol. 2 3 4 
13. I got used to the idea that it happend. 2 3 4 
14. I talked to someone to find out more about the situation. 2 3 4 
15. I kept myself from getting distracted by other thoughts or activities. 2 3 4 
16. I daydreamed about things other than this. 2 3 4 
17. I got upset, and was really aware of it. 2 3 4 
18. I sought God's help. 2 3 4 
19. I made a plan of action. 2 3 4 
20. I made jokes about it. 2 3 4 
21. I accepted that this had happened and that it couldn't be changed. 2 3 4 
22. I held off doing anything about it until the situation permitted. 2 3 4 
23. 1 tried to get emotional support from friends and relatives. 2 3 4 
24. I just gave up trying to reach my goal. 2 3 4 
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RATING SCALE 
1 = I did not do this at all 
2 = I did this a little bit 
3 = I did this a medium amount 
4 = I dill thi~ a lnt 
25. I took additional action to try to get rid of the problem. 2 3 4 
26. I tried to lose myself for a while by drinking alcohol or taking drugs. 2 3 4 
27. I refused to believe that it had happened. 2 3 4 
28. I let my feelings out. 2 3 4 
29. I tried to see it in a different light, to make it seem more positive. 2 3 4 
30. I talked to someone who could do something concrete about the problem. 2 3 4 
31. I slept more than usual. 2 3 4 
32. I tried to come up with a strategy about what to do. 2 3 4 
33. I focused on dealing with this problem and, if necessary, let other things slide 
a little. 2 3 4 
34. I got sympathy and understanding from someone. 2 3 4 
35. I drank alcohol or took drugs, in order to think about it less. 2 3 4 
36. I kidded around about it. 2 3 4 
37. I gave up the auemptto gel what I wanted. 2 3 4 
38. I looked for something good in what was happening. 2 3 4 
39. I thought about how I might best handle the problem. 2 3 4 
40. I pretended that it hadn 'I really happened. 2 3 4 
41. I made sure not to make matters worse by acting too soon. 2 3 4 
42. I tried hard to prevent other things from interfering with my efforts at 
dealing with this. 2 3 4 
43. I went to the cinema or watched television. to think about it less. 2 3 4 
44. I accepted the reality of the fact that it had happened. 2 3 4 
45. I asked people who had had silnilar ex-periences what they did. 2 3 4 
46. I felt a lot of emotional distress and I found myself expressing those feelings a lot. I 2 3 4 
4 7. I took direct action to get around the problem. 2 3 4 
48. I tried to find comfort in my religion. 2 3 4 
49. I forced myself to wait for the right time to do something. 2 3 4 
50. I made fun of the situation. 2 3 4 
51. I reduced the amount of effort I put into solving the problem. 2 3 4 
52. I talked to someone about how I felt. 2 3 4 
53. I used alcohol or drugs to help me get through it. 2 3 4 
54. I learnt to live with it. 2 3 4 
55. I put aside other activities in order to concentrate on this. 2 3 4 
56. I thought hard about what steps to take. 2 3 4 
57. I acted as though it hadn't happened. 2 3 4 
58. I did what had to be done, one step at a time. 2 3 4 
59. I learnt something from the experience. 2 3 4 
60. I prayed more than usual. 2 3 4 
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MULTIDIMENSIONAL HEALTH LOCUS OF CONTROL SCALE (FORM Cl 
This is a questionnaire designed to detennine the way in which different people view their Irritable Bowel Disease 
or Inflammatory Bowel Disease. Each item is a belief statement with which you may agree or disagree. Beside 
each statement is a scale which ranges from strongly disagree (I) to strongly agree (6). For each item we would 
like you to circle the number that represents the extent to which you disagree or agree with the statement. The 
more strongly you agree with a statement, then the higher will be the number you circle. The more strongly you 
disagree with a statement, then the lower will be the number you circle. Please make sure that you answer eve!)' 
item and that you circle only one number per item. This is a measure of your personal beliefs: obviously. there arc 
no right or wrong answers. 
Please answer these items carefully, but do not spend too much time on any one item. As much as you can. try to 
respond to each item independently. When making your choice, do not be influenced by your previous choices. It 
is important that you respond according to your actual beliefs and not according to how you feel you should believe 
or how you think we want you to believe. 
Smmtily Motkrtzuly SU,htly SU,htly ModmzUIJ· Szrongly 
IJimgno nu.., .... DUqru Agne A.fru Asree 
I. If my bowel disease worsens, it is my own 
behaviour which detennines how soon I 
feel better again. 2 3 4 5 6 
2. As to my bowel disease, what will be will be. 2 3 4 5 6 
3. If I see my doctor regularly, I am less likely 
to have problems with my bowel disease. 2 3 4 5 6 
4. Most things that affect my bowel disease 
happen to me by chance. 2 3 4 5 6 
5. Whenever my bowel disease worsens, I should 
consult a medically trained professional. 2 3 4 5 6 
6. I am directly responsible for my bowel disease 
getting better or worse. 2 3 4 5 6 
7. In order for my bowel disease to improve, it is 
up to other people to see that the right things 
happen. 2 3 4 5 6 
8. Whatever goes wrong with my bowel disease 
is my own fault. 2 3 4 5 6 
9. Luck plays a big part in detennining how my 
bowel disease improves. 2 3 4 5 6 
10. Other people play a big role in whether my 
bowel disease improves, stays the same, or 
gets worse. 2 3 4 5 6 
11. Whatever improvement occurs with my bowel 
disease is largely a matter of good fortune. 2 3 4 5 6 
12. The main thing which affects my bowel disease 
is what I myself do. 2 3 4 5 6 
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Sinmaly Mod<NJltly S/igluly S/igluly Mod"'auiJ· Srrong{l' 
Diugru Disogrn IJimgru ,ta .... ,ta .... Agree 
13. If my bowel disease takes a turn for the worse, 
it is because I have not been taking proper care 
of myself. 2 3 4 5 6 
14. The type of help l receive from other people 
detennines how soon my bowel disease 
improves. 2 3 4 5 6 
15. If my bowel disease worsens, it's a matter of 
fate. 2 3 4 5 6 
16. If lam lucky, my bowel disease will get better. 2 3 4 5 6 
17. l deserve the credit when my bowel disease 
improves and the blame when it gets worse. 2 3 4 5 6 
18. Following doctor's orders to the letter is the 
best way to keep my bowel disease from getting 
worse. 2 3 4 5 6 
ROSENBERG'S SELF-PERCEPTION 
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HOSPITAL ANXIETY AND DEPRESSION SCALE 
Health Professionals are aware that emotions play an important part in most illnesses. Titis questionnaire is 
designed to let us know how you feel. Please read each item and underline the reply which comes closest to 
how you have been feeling in the past week. 
Don 'I take too long over your replies; your immediate reaction to each item will probably be more accurate 
than a long thought-out response. 
t. I feel tense or 'wound up': 
Most of the time 
A lot of the time 
From time to time, occasionally 
Not at all 
2. I still enjoy the things I used to enjoy: 
Definitely as much 
Not quite so much 
Only a little 
Hardly at all 
3. 1 ~ a sort of frightened feeling a.~ if something 
awful is about to happen: 
Very definitely and quite badly 
Yes. bu I not too badly 
A lillle, but it doesn't worry me 
Not at all 
4. I can laugh and see the funny side of things: 
As much as I always could 
Not quite as much now 
Definitely not so much now 
Not at all 
5. Worrying thoughts go through my mind: 
A great deal of the time 
A lot of the time 
From time to time but not too often 
Only occasionally 
6. I feel cheerful: 
Not at all 
Not often 
Sometimes 
Most of the time 
7. I can sit at ease and feel reined: 
Definitely 
Usually 
Not often 
Not at all 
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8. I feel as if I am slmH~d down: 
Ne.1rly all the time 
Very often 
Sometimes 
Not at all 
9. I get a sort of frightened feeling like 'butterflies' In 
In the stomach: 
Not at all 
Occasionally 
Quite often 
Vel)' often 
to. 1 ha,·e lost interest in my appearance: 
Definitely 
I don't take as much care as I should 
I may not take quite as much care 
I take just as much care as ever 
t 1. 1 feel re!ltless as if I han to he on the mO\·e: 
Very much indeed 
Quite a lot 
Not vel)· much 
Not at all 
12. I look forward w·ith enjo~·ment to thin~~:s: 
As much as ever I did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all 
13. 1 get sudden fcelin~~:s of panic: 
Very often indeed 
Quite often 
Not very often 
Not at all 
14. 1 can enjoy a ~~:ood book or radio or TV 
programme: 
Often 
Sometimes 
Not often 
Very seldom 
PERCEIVED STRESS SCALE 
The questions in this scale ask you about your feelings and thoughts .---------------, 
during the last month. In each case, you will be asked to indicate how 
often you felt or thought a certain way. Although some of the questions 
are similar, there are differences between them and you should treat 
each one as a separate question. The best approach is to answer each 
question fairly quickly. That is, don't try to count up the number of 
times you felt a particular way, but rather indicate the alternative that 
For each question choose from the 
following alternatives: 
0 =Never 
1 = Almost Never 
2 = Sometimes 
seems like a reasonable estimate. 3 = Fairly Often 
4 =Very Often 
l. In the last month, how often have you been upset because of something 
that happened unexpectedly? 0 
2. In the last month, how often have you felt that you were unable to control 
the important things in your life? 0 
3. In the last month, how often have you felt nervous and stressed? 0 
4. In the last month, how often have you felt confident about your ability to 
handle your personal problems? 0 
5. In the last month, how often have you felt that things were going your 
way? 0 
6. In the last month, how often have you found that you could not cope with 
all the things you had to do? 0 
7. In the last month, how often have you been able to control irritations in 
your life? 0 
8. In the last month, how often have you felt that you were on top of things? 0 
9. In the last month, how often have you been angered because of things that 
happened that were outside of your control? 0 
lO. In the last month, how often have you felt difficulties were piling up so 
high that you could not overcome them? 0 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
THANK YOU FOR YOUR CO-OPERATION IN COMPLETING THIS RESEARCH 
QUESTIONNAIRE BATTERY. 
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APPENDIX4 
RESEARCH QUESTIONNAIRE BATTERY 
OCCUPA TION: .................................................... AGE: ............................ . 
DA TE: ....................................... SEX: MIF 
ROSENBERG'S SELF-PERCEPTION 
CONTROL GROUP 
PARTICIPANT NO: 
Here are some statements that people have used to describe themselves. Please read each statement carefully 
and decide whether you agree with it or not. Please circle the number below (from I to 4) which best describes 
how much in agreement or disagreement you are with it. 
I. I feel that I am a person of worth, at least on an equal plane 
with others. 
2. I feel that I have a number of good qualities. 
3. All in all. 1 am inclined to feel that I am a failure. 
4. I am able to do things as well as most other people. 
5. 1 feel I do not have much to be proud of. 
6. I take a positive attitude towards myself. 
7. On the whole. I am satisfied with myself. 
8. 1 wish I could have more respect for myself. 
9. 1 cenainly feel useless at times. 
10. At times I think I am no good at all. 
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RATING SCALE 
1 = Strongly Disagree 
2 =Disagree 
3 =Agree 
4 = Strongly Agree 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4 
HOSPITAL ANXIETY AND DEPRESSION SCALE 
This questionnaire is designed to let us know how you feel. Please read each item and underline llle repl~· 
which comes closest to how you have been feeling in the past week. 
Don 'I take too long over your replies; your immediate reaction to each item \\ill probably be more accurate 
lllan a long thought-out response. 
I. I feel tense or 'wound up': 
Most of the time 
A lot of llle time 
From time to time, occasionally 
Not at aJI 
2. I still enjoy the things I used to enjoy: 
Definitely as much 
Not quite so much 
Only a little 
Hardly ai aJI 
3. I get a 110rt of frightened feeling as If 110mething 
awful Is about to happen: 
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn 'I worry me 
Not at aJI 
4. I can laugh and see the funny side of things: 
As much as I aJways could 
Not quite as much now 
Definitely not so much now 
Not at aJI 
5. Worrying thoughts go through my mind: 
A great deaJ of the time 
A lot of the time 
From time to time but not loo often 
Only occasionally 
6. I feel cheerful: 
Not at aJI 
Not often 
Sometimes 
Most of the time 
7.1 can sit at ease and feel relued: 
Definitely 
Usually 
Not often 
Not at all 
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8. I feel as if I am slowed down: 
Nearly all the time 
Very often 
Sometimes 
Not at all 
9. I get a 110rt of frfjlhtened feeling like 'butterflie~· in 
In the stomach: 
Not at aJI 
Occasionally 
Quite often 
Very often 
10. I ha,·e lost interest in my appearance: 
Definitely 
I don 'I take as much care as I should 
I may not take quite as much care 
I take just as much care as ever 
11. I feel restless a.• if I have to be on the mon: 
Very much indeed 
Quite a lot 
Not very much 
Not at all 
11. I look forward with enjoyment to things: 
As much as ever I did 
Ralller less than I used to 
Definitely less than I used to 
Hardly at all 
JJ. I get !Ridden feelin11~ of panic: 
Very often indeed 
Quite often 
Not very often 
Not at aJl 
14. I can enjoy a good book or radio or TV 
programme: 
Often 
Sometimes 
Not often 
Very seldom 
PERCEfVEDSTRESSSCALE 
The questions in this scale ask you about your feelings and thoughts r-------------, 
during the last month. In each case, you will be asked to indicate how 
often you felt or thought a certain way. Although some of the questions 
are similar. there are differences between them and you should treat 
each one as a separate question. The best approach is to answer each 
question fairly quickly. That is, don't try to count up the number of 
times you felt a particular way, but rather indicate the alternative that 
For each question choose from the 
following alternatives: 
0= Never 
1 = Almost Never 
2 = Sometimes 
seems like a reasonable estimate. 3 = Fairly Often 
4 = Very Often 
I. In the last month, how often have you been upset because of something 
that happened unexpectedly? 0 
2. In the last month, how often have you felt that you were unable to control 
the imponant things in your life? 0 
3. In the last month, how often have you felt nervous and stressed? 0 
4. In the last month, how often have you felt confident about your ability to 
handle your personal problems? 0 
5. In the last month, how often have you felt that things were going your 
way? 0 
6. In the last month, how often have you found that you could not cope with 
all the things you had to do? 0 
7. In the last month, how often have you been able to control irritations in 
your life? 0 
8. In the last month, how often have you felt that you were on top of things? 0 
9. In the last month, how often have you been angered because of things that 
happened that were outside of your control? 0 
10. In the last month, how often have you felt difficulties were piling up so 
high that you could not overcome them? 0 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
THANK YOU FOR YOUR CO-OPERATION IN COMPLETING THIS RESEARCH 
QUESTIONNAIRE BATTERY. 
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19 June 1998 
Mrs G Cratchley 
54 Wades Road 
Filton 
Bristol BS 12 7ED 
Dear Mrs Cratchley 
SOUTHMEAD IIEALTH 
APPENDIX5 ~~-
Administration Department 
Trust Headquarters 
Southmead Hospital 
Bristol BSI 0 SNB 
Tel: (0117) 959 5207 (direct line) 
Fax: (0 117) 959 0902 
PROJECT No. 45198: HOW DO PEOPLE WITH IRRITABLE BOWEL SYNDROME AND 
INFLAMMATORY BOWEL DISEASE COPE WITH THEIR CHRONIC ILLNESS? A STUI>Y WHICH 
EXAMINES THE DIFFERENCES IN COPING STRATEGIES BETWEEN THESE TWO GROUPS 
I am pleased to inform you that at its meeting on I 0 June 1998, the Medical Research Ethics Committee 
approved your application in respect of the above project. 
Approval is given on the understanding that:-
a) Any ethical problems arising in the course of the project will be reported to the Ethics 
Committee; 
b) Any change in protocol will be reported to the Ethics Committee: 
c) An annual progress report will be submitted and a brief final report on completion. 
Yours sincerely 
Mrs S B Bowman 
Secretary 
Southmead Medical Research Ethics Committee 
• A IJnivrndty or Rril.tnl A'<•oocintrrl Trnc-loinll! Tno~t 
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I 
COPING WITH 
BOWEL 
DISORDERS 
Many people with a bowel disorder find it 
makes their lives more difficult and stressful 
than people who do not have to live with a 
bowel disorder. 
There is a lot of research about the distress 
:xl living with a bowel disorder can create. 
However, I have found that there is hardly any 
research which asks people with a bowel 
disorder how they COPE. 
e.g. How living with a bowel disorder makes 
eople feel, think and behave. 
I am therefore carrying out a study to ask 
people like yourself how YOU COPE with a 
bowel disorder. 
What will happen with the information 
collected? 
The information you g1ve will remam 
anonymous. It will be used to help people in 
the future when they find out they have a bowel 
disorder. 
What would taking part in this study 
involve? 
If you would like to take part in this study it 
will involve a brief conversation and answering 
some questionnaires with the researcher (i.e. 
myself). 
It will take about 1 hour. 
lfyou are willing to take part in this study, 
please fill in your details in the last section of 
this leaflet, tear this section off and return it to 
Dr. Steve Hughes. 
If you do not wish to take part this will not 
affect your treatment. 
THANK YOU FOR READING THIS LEAflET 
I WOULD LIKE TO TAKE PART IN T 
STUDY ABOUT HOW PEOPLE COPE 
WITH BOWEL DISORDERS 
(Please sign your name on the dotted line) 
Please fill out the details below in CAPITAL 
LETTERS. 
NAME: 
ADDRESS: 
TELEPHONE NO ........................................ . 
These details will be given to Gina Cratchley 
(Researcher) who will contact you to arrange 
an appointment. 
0 
Clinical Psychology 
ept: GLOUCESTER 
HOUSE 
Tel: 0117 9595808 
Fax: 
February 1999 
Dear , 
Re: Participation in Research about Coping with a Bowel Disorder 
Thank you for agreeing to take part in the above study. 
I am writing to confinn your appointment on 
This meeting will be held at your home address. 
at 
I have enclosed a Symptom Checklist. Please could you fill this in prior to your appointment. 
I would be grateful if you could telephone the above number if you need to re-arrange this 
appointment. 
I look forward to meeting you. 
Yours sincerely, 
Gina Cratchley 
Researcher 
Enc. 
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Smnhmead Hospital, Westbury-on-Trym 
Bristol BSI 0 5NB 
Switchboard: 0117 950 5050 
A University of Bristol 
Associated NHS Teaching Trust 
SYMPTOM CHECKLIST 
NAME: ..................................................................... . GROUP: IBSIIBD 
DATE: ..................................... . 
Below are a list of 11 symptoms that you may or may not experience. Please read each 
symptom and circle the answer that is true for you. 
Example: I experience diarrhoea NO eMODERATELY STRONGLY SEVERELY 
This person experiences diarrhoea mildly. 
1. I experience diarrtloea NO MILDLY MODERATELY STRONGLY SEVERELY 
2. I experience constipation NO MILDLY MODERATELY STRONGLY SEVERELY 
3. I experience abdominal pain NO MILDLY MODERATELY STRONGLY SEVERELY 
4. I experience rectal bleeding NO MILDLY MODERATELY STRONGLY SEVERELY 
5. I experience passing mucus NO MILDLY MODERATELY STRONGLY SEVERELY 
6. I experience abdominal 
bloating NO MILDLY MODERATELY STRONGLY SEVERELY 
7. I experience incomplete 
evacuation of my bowel NO MILDLY MODERATELY STRONGLY SEVERELY 
8. I experience tiredness NO MILDLY MODERATELY STRONGLY SEVERELY 
9. I experience nausea NO MILDLY MODERATELY STRONGLY SEVERELY 
10. I experience difficulty in 
swallowing NO MILDLY MODERATELY STRONGLY SEVERELY 
11 . I experience the need to 
urinate frequently NO MILDLY MODERATELY STRONGLY SEVERELY 
Please write down below any other symptoms you experience which are not on the list. 
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APPEND1X8 
SOUTHM 
Dcpt: 
Tel: 
Fax: 
~~-
Clinical Psychology 
GLOUCESTER 
HOUSE 
(0 117) 9595808 
VOLUNTEERS FOR THE HEALTH STUDY 
Dear Volunteer, 
Thank you for agreeing to take part in this study. This study aims to help research in to how 
people cope with bowel disorders, such as Irritable Bowel Syndrome, Crohn's Disease, 
Ulcerative Colitis etc. 
Please make sure that you do NOT have any of these disorders, nor any other major health 
problems as they will disqualify you from taking part. 
Please fill in the enclosed questionnaire battery, 4 questionnaires in total. There are 
instructions at the top of each questionnaire which will help you to fill it in. 
Your participation should take between 15- 30 minutes. 
The information you provide will remain anonymous and on completion of the study (around 
June 1999) will be destroyed. 
Please return in the envelope provided. 
MANY THANKS FOR YOUR HELP. 
Yours sincerely, 
Glna Cratchley 
Researcher 
Encs. 
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Southmcad Hospital, Westbury·on·Trym 
Bristol liS I 0 5 N ll 
Switchboard: 0117 950 5050 
A University of Bristol 
Associated NHS Teaching Trust 
APPENDIX 9 
. 7~------------------------------------------~ 
.6 
.5 
.4 
.3~----------~----------------~----------~ 
N= 29 29 
Prop. Problem F.C. Prop. Emotion F.C. 
Triangle = extreme out/ier; Circle = minor outlier 
Fig. I: Boxplots ofthe Proportion of Problem-Focused and the Proportion of 
Emotion-Focused Coping. 
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Fig. 2: Scatterplot of the Positive Correlation between the Total Amount of 
Problem-Focused Coping and the Total Amount of Emotion-Focused Coping. 
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